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ABSTRACT
Burden of Illness among Elderly Individuals with Parkinson’s disease
Sandipan Bhattacharjee, B. Pharm., M.S.

Parkinson‟s disease (PD) is the second most common neurodegenerative disease affecting an
estimated one million individuals in the United States (U.S.) and five million individuals
globally. With increasing age, the prevalence of PD also increases. Challenges of PD include
high economic burden of formal care, informal caregiving burden, and also management of a
chronic illness (e.g. type 2 diabetes mellitus) in the presence of PD. The purpose of this study
was to use observational data from real-world settings to provide a comprehensive view of the
burden of illness among elderly individuals with PD by assessing the formal economic burden,
informal caregiving burden and the state of management of chronic illness with complexity
(CIC) in the presence of two debilitating conditions (PD and type 2 diabetes mellitus). This study
used a triangulation approach by using three different datasets: (i) National Medicare 5% sample
claims database to evaluate the formal economic burden; (ii) the National Alliance for
Caregiving (NAC) data to assess the informal caregiver burden; and (iii) the nationwide claims
database of Humana Medicare Advantage Part D enrollees to evaluate the state of management
of chronic illness with complexity. The specific aims of the three studies were: (1) among elderly
Medicare beneficiaries aged 65 or older, estimate excess home healthcare use and expenditures
among individuals with PD compared to individuals without PD and analyze predisposing,
enabling, need factors, personal health behaviors, and external environment associated with
excess home healthcare use and expenditures among individuals with PD; (2) assess the informal
caregiver burden and estimate costs associated with informal caregiving burden among
caregivers providing care to elderly individuals; and (3) assess process, and intermediate clinical
outcomes of diabetes care among individuals with chronic illness with complexity defined as cooccurring PD and diabetes. From the results of the first study, we found that elderly Medicare
beneficiaries with PD had significantly higher home healthcare use and expenditures compared
to those without PD. The differences in home healthcare use and expenditures among elderly
Medicare beneficiaries with and without PD were mainly explained by personal health behaviors
such as baseline resource use and need factors such as physical and mental health conditions. In
terms of the economic burden of informal caregiving, we did not observe a significant difference
in informal caregiving costs between caregivers of elderly individuals with and without PD,
despite the costs of informal caregiving for elderly individuals with PD being 1.27 times higher
than those without PD. Individuals with CIC were less likely to achieve American Diabetes
Association recommended annual HbA1c and lipid testing goals compared to those without CIC
(T2DM without PD). However, individuals with CIC achieved glycemic and lipid control
outcomes. Thus, these findings taken together underscore the advantage of using an integrated
delivery system with better care coordination and providing “holistic care approach.” As
majority of elderly individuals with PD are community-dwelling, novel intervention techniques
are needed to be developed to reduce the informal caregiving burden.
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CHAPTER 1

BACKGROUND

Prevalence of Parkinson’s disease
Parkinson‟s disease (PD) is the second most common neurodegenerative disease affecting
an estimated one million individuals in the United States (U.S.) and 5 million individuals
globally (Olanow, Stern, & Sethi, 2009). With increasing age, the prevalence of PD also
increases. The prevalence of PD is estimated to be 1% among individuals 60 years or older
(Olanow et al., 2009) and it increases to 4% among individuals 80 or older (Terriff et al. 2012). It
has also been projected that there will be a two-fold increase in the number of individuals with
PD by 2030 (Dorsey, 2007). In the US, projections indicate a substantial increase in the number
of elderly individuals (baby-boomers) and as the prevalence of PD increases with age, it is
important to study the healthcare management of elderly individuals in order to achieve better
health outcomes and decrease the steeply rising cost curve among this population.
Parkinson’s disease and economic burden among elderly
It has been observed that despite the low prevalence of PD, individuals with PD
experience substantially higher healthcare expenditures compared to those without PD (Noyes et
al., 2006; Olanow, Stern, & Sethi, 2009). In the United States (U.S.), a nationally representative
study of Medicare beneficiaries found that the average healthcare expenditures among
individuals with PD were approximately twice as high as those without PD (Noyes et al., 2006).
As the prevalence of elderly individuals is estimated to rise significantly over the next couple of
decades, there will be a consequent increase in the prevalence of individuals with PD. As the
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elderly individuals with PD experience high economic burden due to their disease state, the
increase in the prevalence of elderly individuals with PD can be a major public health concern.
Parkinson’s disease and home healthcare
Limitations of ADLs, IADLs, motor and non-motor symptoms, cognitive impairment,
behavioral issues and greater need for home health care among individuals with PD can lead to
greater caregiving needs for individuals with PD. This has also translated into higher home
healthcare use and expenditures among individuals with PD. Indeed, in all the studies that have
compared healthcare expenditures among individuals with and without PD (Bhattacharjee &
Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein, Chrischilles, &
Voelker, 1997), a consistent finding has been greater home healthcare expenditures among
individuals with PD compared to those without PD. However, none of these studies has
systematically examined the contributors to excess home health expenditures among individuals
with PD. This study extends previous studies by not only providing estimates of formal and
informal caregiving but examining the factors that contribute to excess formal caregiving
expenditures by analyzing the individual-level factors associated with them.
This provides the rationale for our Aim 1, which estimates the excess home healthcare
use and expenditures associated with PD and examine factors associated with this excess use and
expenditures. This study aim was accomplished by conducting a comparative analysis of
individuals with and without PD. This aim further quantifies the extent to which each of the
different set of factors can explain excess home healthcare expenditures among individuals with
PD compared to those without PD.

Page 10 of 129

Parkinson’s disease and informal care giver burden
In addition to formal home healthcare, individuals with PD also rely on home healthcare
provided by informal caregivers. As the majority of elderly individuals with PD live in
communities, caregiving is mainly provided by spouse or children of individuals with PD (Lau
2011). When caregiving is provided by close family members, relatives, or friends who do not
have any organizational affiliations or certificates for caregiving they are considered as informal
caregivers (Rakoski, 2012). Some studies have documented that caregivers of PD suffer from
substantial caregiving burden because of fear or uncertainty, shift in roles, financial burden,
social isolation, little time alone, demands of constant care and feel of guilt. In fact, many
informal caregivers spend on an average 96 hours/week providing care to individuals with PD
(Parish 2003).
This leads us to Aim 2, which was to assess caregiver burden of individuals providing
care to elderly (age ≥ 65 years) individuals with PD compared to caregivers of elderly
individuals without PD and to estimate costs associated with providing informal care to elderly
individuals with PD compared to informal caregiving of elderly individuals without PD.
Parkinson’s disease and diabetes
One of the drivers of formal and informal home healthcare use and expenditures is the
presence of complexity in PD. Individuals with PD can have co-occurring chronic conditions
including type 2 diabetes mellitus (T2DM), which may increase economic and morbidity burden.
Of specific importance is the presence of T2DM and PD because co-occurring T2DM among
individuals with PD is associated with substantially (over five times) higher home healthcare
expenditures compared to matched controls without PD but with diabetes (Bhattacharjee &
Sambamoorthi 2013). In addition, biological and epidemiological connections between T2DM
and PD have been considered, although the relationship remains inconclusive. Furthermore,
Page 11 of 129

studies on diabetes care among individuals with multimorbidity have not proven that guidelineconsistent diabetes care can actually improve quality and outcomes of care (Woodard, Urech,
Landrum, Wang, & Petersen, 2011; Fischer et al., 2000).
Therefore, it is important to assess the state of diabetes care among individuals with PD
and the association between CIC and outcomes and quality of diabetes care. This provides the
rationale for our Aim 3, which is to assess process, outcomes, and quality of diabetes care among
individuals with chronic illness with complexity defined as co-occurring PD and diabetes.
As PD has a higher prevalence among elderly (≥ 65 years) than among other age groups,
most of these individuals will be eligible for Medicare. Therefore, most of healthcare spending
will be borne by Medicare. Although less than 5% of total spending was for home health care,
Medicare home healthcare spending has grown substantially over the past decade. Indeed, in
2010, Medicare spending on home healthcare was estimated at $19.4 billion (Health Care
Spending-Medicare). Because of the escalating home healthcare expenditures Centers for
Medicare and Medicaid Services (CMS) has been exploring ways to reduce the excess home
healthcare expenditures. It has been estimated that individuals with PD accounts for a significant
portion of home healthcare visits (National Home and Hospice Care Survey, 2011). Therefore,
an understanding of factors contributing to home healthcare among all elderly and specifically
those with PD who are high utilizers of home healthcare is critical.
Although individuals with PD rely on formal home healthcare, informal care continues to
be one of the main components of home health care received by individuals with PD. Care givers
of individuals with PD often suffer from poor quality of life, financial burden, social isolation,
little time alone, demands of constant care and feel of guilt. Some studies have evaluated
informal caregiver burden among individuals with PD. These studies are limited by geographical
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locations within the U.S. (Edwards & Ruettiger, 2002). Many of these studies are outdated with
data from as early as1999 (Parrish et al., 2003). Additionally, none of these studies estimated
costs associated with informal caregiving among caregivers of individuals with PD. As the
number of elderly individuals as well as those with PD are expected to increase substantially
over the next decade, it can also be expected that there will be higher needs for informal
caregiving for these aging population. In this context, it is important to identify caregivers who
are at high risk for high care burden so that programs and interventions can be developed to
improve the well-being of the caregivers.
As stated before, chronic illness with complexity is a major issue among individuals with
PD because of the prevalence of other chronic conditions including diabetes. Almost all clinical
practice guidelines are developed based on the expert consensus and the scientific evidence for a
single disease state (Boyd et al., 2005) rather than for multiple conditions. There are separate
guidelines for treating diabetes (such as the guidelines of the American Diabetes Association)
and PD (European Parkinson's Disease Standards of Care Consensus Statement). Therefore, it is
not known as to whether guideline consistent care is provided to individuals with co-occurring
chronic conditions and so it is important to explore the current state of standards of care and
health outcomes among individuals with co-occurring chronic conditions such as T2DM and PD.
PURPOSE OF THIS STUDY
The purpose of this study was to use observational data from real-world settings to
provide a comprehensive view of the burden of illness among elderly individuals with PD by
assessing the economic burden, informal caregiving burden and the state of management of
chronic illness with complexity in the presence of two debilitating conditions (PD and type 2
diabetes mellitus). This study used a triangulation approach by using data from different sources
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to answer the specific aims as there is no single data available that consists of all the variables
used in this study. We used the National Medicare 5% sample claims database to evaluate the
economic burden. To assess the informal caregiver burden, we used the nationally representative
sample of National Alliance for Caregiving (NAC) data. To evaluate the state of management of
chronic illness with complexity, we used the nationwide sample of Humana Medicare Advantage
Part D enrollees.
Aim 1: Among elderly Medicare beneficiaries aged 65 or older, estimate excess home
healthcare use and expenditures among individuals with PD compared to individuals
without PD and analyze predisposing, enabling, need factors, personal health behaviors,
and external environment associated with excess home healthcare use and expenditures
among individuals with PD.
Objective 1.1: Among elderly Medicare beneficiaries aged 65 or older, estimate excess
home healthcare use among individuals with PD compared to individuals without PD.
Hypothesis 1.1: We hypothesized that elderly Medicare beneficiaries with PD will be more likely
to have home healthcare use compared to those without PD after adjusting for predisposing
(age, gender, race/ethnicity), enabling (public assistance), need [(co-occurring chronic
conditions), healthcare use (baseline healthcare use)], personal health behaviors (substance use,
baseline resource use), and external environmental (census region, metro-status) factors.
Aim 1.2: Among elderly Medicare beneficiaries aged 65 or older and among users of home
healthcare, estimate excess home healthcare expenditures among individuals with PD
compared to individuals without PD.
Hypothesis 1.2: We hypothesized that home healthcare expenditures among individuals with PD
will be higher compared to those without PD after adjusting for predisposing (age, gender,
race/ethnicity), need (co-occurring chronic conditions), personal health behaviors (substance
use disorders, baseline resource use), and external environmental (census region, metro-status)
factors.
Objective 1.3: Analyze the extent to which differences in predisposing, enabling, need
factors, personal health behaviors, and external environment characteristics between PD
and no PD groups contribute to the excess home healthcare use and expenditures among
elderly Medicare beneficiaries with PD.
Hypothesis 1.3: We hypothesized that differences in need factors as measured by co-occurring
chronic condition will explain higher rates of home healthcare use and expenditures among
elderly Medicare beneficiaries with and without PD.
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Aim 2: Assess the informal caregiver burden and estimate costs associated with informal
caregiving burden among caregivers providing care to elderly individuals (age ≥ 65 years).
Objective 2.1: To assess caregiver burden of individuals providing care to elderly carerecipients with PD compared to caregivers of elderly care-recipients without PD.
Hypotheses 2.1: We hypothesized that informal caregivers of individuals with PD will have
higher burden compared to the caregivers of individuals without PD after adjusting for carerecipient and caregiver characteristics.
Objective 2.2: To estimate costs associated with providing informal care to elderly
individuals with and without PD.
Hypotheses 2.2: We hypothesized that costs of providing informal care to individuals with PD
will be higher than costs of providing informal care to individuals without PD after adjusting for
care-recipient and caregiver characteristics.
Aim 3: To assess process and intermediate clinical outcomes of diabetes care among
individuals with chronic illness with complexity defined as co-occurring PD and diabetes.
Objective 3.1: Evaluate diabetes process of care among elderly individuals with CIC
(T2DM and PD) compared to those without CIC (T2DM and no PD) within a multivariate
framework.
Hypothesis 3.1: We hypothesized that the process of diabetes will be poor among elderly
individuals with CIC (T2DM and PD) compared to those without CIC (T2DM without PD)
within a multivariate framework.
Objective 3.2: Examine intermediate clinical outcomes among elderly individuals with CIC
(T2DM and PD) compared to those without CIC (T2DM without PD) within a multivariate
framework.
Hypothesis 3.2: We hypothesized that the intermediate clinical outcomes will be poor among
elderly individuals with CIC (T2DM and PD) compared to those without CIC (T2DM without
PD) within a multivariate framework.
SIGNIFICANCE OF THE STUDY
The present study makes a unique contribution to the knowledgebase by evaluating
economic burden, informal caregiver burden and the state of management of chronic illness with
complexity with two debilitating diseases (PD and type 2 diabetes mellitus) of individuals with
PD and caregivers of PD. To the best of our knowledge, no study till date has been conducted to
provide a holistic view of PD healthcare management by focusing on all these different aspects.
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Moreover, as the population of United States is aging, these studies are timely and appropriate as
they focus on an aging problem such as PD, which may become a major public health concern in
the near future. Furthermore, the datasets used for each of the specific aims of this dissertation is
a nationally representative or nationwide data. Till date, there are no studies available that have
used a nationally representative or nationwide data to answer these research questions from
home healthcare perspective. Using observational data from real-world settings, this dissertation
will fill this critical knowledge gap on the economic burden, caregiver burden and the state of
management of chronic illness with complexity among elderly individuals with PD by providing
estimates at national level.
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CHAPTER 2: Home Care Use and Expenditures and Parkinson’s disease among Elderly
Medicare Beneficiaries: An Application of Decomposition Technique
INTRODUCTION
Parkinson’s disease and home healthcare expenditures
Despite the low prevalence of Parkinson‟s disease (PD) (approximately 1-2% in
individuals 60 years or older), individuals with PD experience substantially higher healthcare
expenditures compared to those without PD (Noyes, Liu, Li, Holloway, & Dick, 2006; Olanow,
Stern, & Sethi, 2009). Specifically, home healthcare expenditures have been observed to be
consistently and substantially higher among individuals with PD compared to those without PD
(Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein,
Chrischilles, & Voelker, 1997). The magnitude of the difference varied depending on the year in
which the studies were conducted. Using data from Medicare Current Beneficiary Survey
(MCBS) it has been reported that average annual home healthcare expenditures among elderly
Medicare beneficiaries with PD (US$1,422) was 3.2 times as high as home healthcare
expenditures compared to those without PD (US$448) expressed in 2002 US dollars (Noyes et
al., 2006). Another recent study conducted using Medical Expenditure Panel Survey data on
community-dwelling elderly individuals aged 65 years or older living in the U.S., which used
propensity score matching to derive no PD group, found that individuals with PD had
approximately 2.5 times higher home healthcare expenditures ($2,559) compared to those
without PD ($1,017) expressed in 2009 dollars (Bhattacharjee & Sambamoorthi, 2013). Among
users of home healthcare, similar differences were found between elderly individuals with and
without PD.
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PD and home healthcare use
Home healthcare use has also been shown to be higher among elderly with PD compared
to those without PD. Rates of home healthcare use among community-dwelling Medicare
beneficiaries with PD were 3.5 times as high as those without PD (Noyes et al., 2006). Among
community-dwelling and institutionalized elderly (age 65 years or older) Medicare beneficiaries
participating in the National Long-Term Care Survey (NLTCS), it was observed that home
healthcare use among Medicare beneficiaries with PD was two times as high as those without
PD. This study suggested that the presence of co-occurring conditions contributed to higher use
of home healthcare services among individuals with PD compared to those without PD (Pressley
et al., 2003). Unpublished data from the authors (Bhattacharjee & Sambamoorthi, 2013) revealed
that home healthcare use among individuals with PD was two times as high as those of
propensity-score matched individuals without PD.
Factors associated with home healthcare use and expenditures
Higher home healthcare use and expenditures among elderly with PD can be due to many
factors. PD is characterized by bradykinesia (difficulty or slowness of starting movements),
resting tremors (shaking of limbs involuntarily), rigidity (stiffness of arms, legs, and/or neck),
and imbalance (Park & Stacy, 2009; Vickers & O'Neill, 1998). These physical conditions can
lead to difficulties in carrying out activities of daily living (ADLs) and instrumental activities of
daily living (IADLs). Common geriatric issues such as medication management is particularly
challenging in PD population because of “on-off” phenomenon with medication therapies.
Additionally, individuals with PD may require greater surveillance at home to monitor the sideeffects of antiparkinsonian (APD) medications, decline in effectiveness of APD medications and
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worsening of PD symptoms (Vickers & O'Neill, 1998). Moreover, APDs can induce cognitive
decline, which may require careful monitoring at home (Moore & O'Keeffe, 1999). Furthermore,
home healthcare professionals are required for individuals with PD to alter their diet, understand
sleep cycle disturbances and teach newer techniques to execute ADLs and IADLs (Vickers &
O'Neill, 1998). While all these problems are common among many elderly, PD presents
particular challenges. For example, findings from a study that compared functional problems
experienced by caregivers and care-recipients suggested that those with PD have greater home
healthcare needs (Parrish, Giunta, & Adams, 2003) compared to other cognitively impaired
(stroke, Alzheimer‟s disease, multi-infarct dementia, other degenerative disease/dementia,
traumatic brain injury, brain tumor, other non-degenerative disease, multiple sclerosis,
amyotrophic lateral sclerosis, or unreported diagnosis) individuals. According to this study, PD
care-recipients reported on an average 10 functional problems which included difficulties in
ADLs (eating, bathing, dressing, toileting, transferring), and IADLs (taking medication,
performing household chores, managing money/finances).
Although not specific to PD, previous literature suggests that limitations of ADL, IADL,
cognitive impairment, older age, as well as co-occurring chronic diseases were associated with
higher home healthcare use (Fortinsky, Fenster, & Judge, 2004; Henton, Hays, Walker, &
Atwood, 2002; Moon & Shin, 2006). A study conducted among Medicare-Medicaid dual eligible
using data from Connecticut Long Term Care Health (CLTC) between the time period of August
1995 to December 1997 found that higher limitations of activities of daily living (ADLs),
dependence in walking and climbing stairs, and mild cognitive impairment were statistically
significantly associated with higher Medicare home healthcare use and expenditures (Fortinsky
et al., 2004). Using data from 1996 Medical Expenditure Panel Survey (MEPS), it was observed
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that among elderly individuals (aged 65 years or older) being old-old, non-white, and having
greater functional limitations were associated with higher per-capita annual Medicare home
healthcare expenditures (Henton et al., 2002). Another study using data from 1996-2000 MEPS
among Medicare-Medicaid dual eligible population found that poor health and co-occurring
chronic diseases were significantly associated with higher home healthcare use (Moon & Shin,
2006).
Need for the study
As PD has a higher prevalence among elderly (≥ 65 years) than among other age groups,
most of these individuals are eligible for Medicare. Therefore, most of home healthcare spending
will be borne by Medicare. Indeed, in 2010, Medicare spending on home healthcare was
estimated at $19.4 billion (Health Care Spending-Medicare). Although less than 5% of total
spending was for home health care, Medicare home healthcare spending has grown substantially
over the past decade. It has been estimated that total Medicare home healthcare expenditures
increased from by 129% between 2000 and 2010 (Home Healthcare Services-Chapter 8). This
steep increase has been partly attributed to the aging population of the United States (U.S.). The
number of home healthcare users also increased from 2.5 million to 3.4 million between 20022010 (Health Care Spending-Medicare).
According to the 2007 National Home and Hospice Care Survey (NHHCS), diabetes
(10.1%), diseases of central nervous system (8.4%), were the top two common primary
diagnoses at the time of home healthcare visit (National Health Statistics Report 2011). Among
diseases of the central nervous system, nearly 15% of the home healthcare visits were for
individuals with PD. Because of the escalating home healthcare expenditures Centers for
Medicare and Medicaid Services (CMS) has been exploring ways to reduce the excess home
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healthcare expenditures. Thus, an understanding of factors contributing to home healthcare
among all elderly and specifically those with PD who are high utilizers of home healthcare is
critical. However, to the best of authors‟ knowledge, no study has analyzed various factors
associated with higher home healthcare use and expenditures among individuals with PD.
Therefore, the primary purpose of the study was to estimate excess home healthcare use and
expenditures associated with PD and examine factors associated with excess use and
expenditures.
The current study further highlighted the extent to which each of the different set of
factors explain excess home healthcare use and expenditures among individuals with PD
compared to those without PD. The current study used data on 5% sample of nation-wide feefor-service Medicare beneficiaries.
Medicare and Home Healthcare
As the current study focuses on elderly Medicare beneficiaries, we briefly describe the
eligibility requirements to receive Medicare paid home healthcare services, as well as the
services covered under Medicare. To be eligible to receive home healthcare services an elderly
Medicare beneficiary must satisfy the following criteria: (1) need of a part-time (less than 8
hours/day) or sporadic skilled care (care obtained from a nurse, physical, or speech therapist); (2)
not able to leave their house without help from others or without considerable self-effort; (3)
certification from a physician stating the need for home healthcare; and (iv) home healthcare
should be provided according to a care plan established by a physician, and the care should also
be regularly reviewed by the physician.
Starting in 2000, the CMS adopted a prospective payment system (PPS) which pays for
home healthcare in a 60-day episode at a predetermined rate. The payment rates are adjusted in
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terms of severity of the beneficiary (condition of the beneficiary and service use) and also to
reflect the level of market input prices based on the geographical area of service delivery
(MedPAC payment basis). The severity of beneficiaries is calculated on the basis of case-mix
index that depends on the beneficiaries‟ clinical and functional characteristics as well as certain
services that they might use. In case of less than 5 visits during a 60-day episode, the home
health agency is reimbursed on the basis of visit rather than by type of visit. The payments are
also modified under certain circumstances as for instance when there are high-cost outliers. After
the end of the initial 60-day period, if further home healthcare service is needed then that is
counted as a new episode (Home Healthcare Services-Chapter 8).
Conceptual Framework
The conceptual behavioral model by Andersen was used to examine the predisposing,
enabling, need, personal health choices and external environmental factors associated with the
healthcare expenditures (Andersen, 1995). The Andersen Behavioral Model (ABM) has been
used in various studies related to usage of health services (both healthcare use and expenditures).
The ABM posits an individual‟s use of health services as a function of (1) predisposing, (2)
enabling, (3) need factors, (4) personal health choices and (5) external environment. The
individual‟s characteristics that are predisposing include demographic characteristics (e.g.
gender, age, race/ethnicity). The ability of an individual to access a health service is termed as an
enabling factor (e.g. public assistance). Need factors are represented by a subjective
acknowledgement of need such as a patient‟s symptoms, or a professional‟s judgment of the
need for healthcare based on disease characteristics. Personal health choices and external
environment characteristics also influence an individual‟s use of health services.
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Figure 1: Andersen Behavioral Model
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METHODS
Study Design
We used a retrospective, observational, cohort study design. For the purposes of this
study we used the Medicare 5% sample claims database for years 2006-2007.
Data Source: Medicare Five-Percent Sample Claims Database
The Medicare 5% sample claims database contains all final action claims data for a
random five percent sample of all claims of Medicare beneficiaries
(http://aspe.hhs.gov/datacncl/datadir/cms.htm). Available standard analytic files (SAF) in
Medicare 5% sample claims database are: (1) inpatient, (2) outpatient (encompassing claims
from physician office), (3) skilled nursing facility, (4) carrier, (5) hospice care, (6) home health,
and (7) durable medical equipment analytic data files. The Medicare 5% sample claims database
can be used to conduct both cross-sectional and longitudinal studies. A unique, de-identified
Medicare beneficiary identifier is assigned to each enrollee, which is used to follow them
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Healthcare
Expenditures

longitudinally. Several studies have been conducted using this database (Bozic et al., 2012;
Bozic et al., 2013; Escarce & McGuire, 2003). The information recorded in the claims dataset
include dates of service provided, charge and payment amounts, clinical diagnosis codes, as well
as procedure codes. Information on demographic characteristics such as age, gender, and
race/ethnicity are available in the denominator files of Medicare claims dataset.
The SAF for home healthcare consist of fee-for-service claims for Medicare-certified
services, service dates, claim payment amount, primary diagnosis code (ICD-9-CM codes), up to
9 other diagnosis codes, and total number of home healthcare visits. In the home healthcare SAF,
the service begin and end dates does not necessarily reflect dates of services and some of the
detailed information on types of care received by Medicare beneficiaries are available in revenue
center files.
Study Population:
Our study population comprised of community-dwelling elderly Medicare beneficiaries
aged 65 years and older. Additionally, we required that the elderly Medicare beneficiaries have
continuous Medicare Part A and B enrollment for 2006 and 2007. Medicare individuals enrolled
in Health Maintenance Organizations (HMO) were excluded due to unavailability of HMO
claims in the Medicare 5% sample database. Individuals with PD were identified using
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
codes of 332.xx in calendar year 2006. Previous literature has shown that identifying PD
individuals with ICD-9-CM codes from Medicare database to be reliable with modest sensitivity
(61.13%) and positive predictive value (65.13%), and the very high specificity (99.08%) when
all standard analytic files were used (Noyes, Liu, Holloway, & Dick, 2007). To be included in
the final study sample, individuals with and without PD were required to have positive direct
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healthcare expenditures. Individuals with end-stage renal disease (ESRD) as well as those
without full year enrollments due to death or some other reason were excluded from the final
sample.
Measures
Dependent Variable:
Home healthcare Use
Home healthcare visits were identified from the home healthcare SAF. Elderly Medicare
beneficiaries with any home healthcare visit during 2007 were considered to be home health
users.
Healthcare Expenditures
Among users of home healthcare, we examined home healthcare expenditures. We used
actual Medicare payments to estimate home healthcare expenditures from home healthcare file.
Expenditure data are generally skewed to the right. Therefore, we transformed expenditures with
natural logarithm.
Key Independent Variable: PD and no PD
Presence or absence of PD constituted the key independent variable for this study.
Presence of PD was ascertained by using ICD-9-CM codes of 332.xx during 2006 calendar year.
Other Independent Variables
The predisposing characteristics comprised of gender (male/female), race/ethnicity
(white, African American, Latino and other), and age (65-74; and 75 years and older). Enabling
characteristics will consist of public assistance (which was indicated by Medicare premiums and
deductibles that were subsidized by the state keeping in view the financial status of the enrollee).
The need factors constituted of co-occurring chronic conditions. Healthcare behavior consisted
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of substance use disorders that included alcohol, tobacco and drug use. This domain also
included baseline healthcare use. The external environment factors comprised of census region
and metro status.
Statistical Methods
Statistically significant differences in home healthcare use in 2007 by presence of PD
were ascertained with chi-square tests. We used logistic regressions to examine the association
between home healthcare use and PD after controlling for predisposing, enabling, need factors,
personal health behaviors and external environment.
We examined the differences in average home healthcare expenditures between PD and
no PD groups by using t-tests. We also conducted Ordinary Least Square (OLS) regressions on
logged home healthcare expenditures in 2007 adjusting for all the independent variables to
examine the relationship between PD and home healthcare expenditures.
Post-Regression Linear Decomposition of Home Healthcare Expenditures
The Blinder and Oaxaca decomposition technique has been used for several decades
after it was initially developed to explain wage differentials between men and women (Oaxaca,
1973). Blinder-Oaxaca decomposition technique can be expressed with the following sets of
equations:
Yi = β0i + Σnj=1Xiꞌβi + €i
Where Yi represents the dependent variable (in this case logged home healthcare
expenditures) for ith individual who may or may not have PD; Xꞌ represents the vector of
independent variables such predisposing, enabling, need, personal health behavior and external
environment factors which may be associated with home healthcare expenditures; βi is the
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parameter vector and €i is the error term which follows a standard normal distribution (0, σ€); and
β0i is the estimated intercept.
According to the Blinder-Oaxaca decomposition technique, the difference in logtransformed home healthcare expenditures among individuals with and without PD can be
expressed as follows:
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Where the intercepts of the OLS regressions among individuals with and without PD are
represented respectively as ˆ0PD andˆ0NPD ; the estimated jth coefficient of the OLS regression
among individuals with and without PD are represented as ̂ jPD and ̂ jNPD respectively; and the
average distribution of the jth measured characteristics among individuals with and without PD
are represented by X PD
and X jNPD respectively. The estimated differences in expenditures can
j
be divided further into two components: explained and unexplained differences.
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The explained portion of the gap is the sum of the differences between individuals with
and without PD in terms of the observed or measured characteristics weighted by the estimated
coefficients of individuals with PD. The unexplained portion of the gap represents the sum of the
differences of the estimated coefficients between individuals with and without PD weighted by
the estimated coefficient of individuals without PD. There is an „index-number‟ problem that
exists in this approach which arises based on the group which is taken as reference. As for
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instance, the estimated explained and unexplained gaps might differ depending on whether
individuals with PD or without PD are taken as the reference. One possible solution to this
problem suggested by Neumark (1988) is to use the regression estimates from pooled
regressions. The equation for Neumark‟s decomposition using the pooled regression coefficient
is as follows:
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regression pooled regression coefficient)
coefficient)

According to the Neumark‟s decomposition using the pooled regression coefficient, the
explained portion of the gap is the sum of the differences between individuals with and without
PD in terms of the observed or measured characteristics weighted by the estimated pooled
coefficients of the regression. The unexplained portion of the gap in this case represents the sum
of the differences of the estimated coefficients between individuals with and without PD
weighted by the estimated pooled coefficient of regression. In this study we report estimates
from pooled, individuals with PD, and individuals without PD regressions to differentiate
between the explained and unexplained portion of the home healthcare costs among individuals
with and without PD (Neumark 1988).
Post-Regression Non-Linear Decomposition of Home Healthcare Use
To assess the extent to which differences in home healthcare use among individuals with
and without PD can be explained by predisposing, enabling, need factors, personal health
behaviors and external environment we used a post-regression non-linear decomposition
technique. The differences in home healthcare use between the two groups of elderly individuals
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with and without PD are compartmentalized into two parts: 1) one part is attributable to the
differences in characteristics, which is the explained portion of the differences and 2) the other
part is the differences attributable to differences in coefficients. The contribution of each of the
individual-level factors to the gap in terms of home healthcare use between the two groups is
estimated by the change in the mean predicted probability by superimposing the distribution of
elderly Medicare beneficiaries with PD to those without PD, keeping all other factors constant
(Fairlie, 2003). Some of the common problems associated with the non-linear decomposition
techniques include the “index number” problem and path dependency. The multivariate
technique developed by Powers et al. 2011overcomes the “index number” problem by using
pooled coefficients. Moreover, the mvdcmp technique of Powers et al. 2011, uses an algorithm
that helps in transforming the estimates from the general regression equation using an ANOVAtype or centered-effects restriction into normalized equation. This helps in overcoming the bias
due to reference groups.
All analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC) and
STATA version 13.0. Microsoft Excel 2010 was used to perform the Blinder-Oaxaca linear
decomposition and multivariate non-linear decomposition.
RESULTS
Table 1 displays the description of the study sample. The study sample consisted of
10,865 elderly Medicare beneficiaries with PD and 997,785 elderly Medicare beneficiaries
without PD. In terms of predisposing, enabling, personal health behavior, need and external
environmental factors, all the characteristics were statistically significantly different between
elderly Medicare beneficiaries with and without PD except for baseline substance use disorder
and cancer.
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Predisposing characteristics: Among elderly Medicare beneficiaries with PD, a higher
percentage were men (50.1%) and among those without PD a significantly lower percentage
were men (39.8%). A greater proportion of elderly Medicare beneficiaries with PD were 75 years
and older (63.9%) and a lower proportion of elderly Medicare beneficiaries without PD were 75
years and older (48.5%). The study sample consisted of an overwhelming majority of whites in
both the groups (around 90% in both groups).
Enabling characteristics: A higher percentage of elderly Medicare beneficiaries were on public
assistance among those with PD (16.0%) compared to those without PD (11.4%).
Need characteristics: Significantly higher proportion of elderly Medicare beneficiaries with PD
had mental health conditions such as anxiety (10.9% vs 5.9%) and depression (23.6% vs. 8.8%)
compared to those without PD. In terms of the physical health conditions, elderly Medicare
beneficiaries with PD compared to those without PD had a higher proportion of arthritis (33.9%
vs. 29.5%), Chronic Obstructive Pulmonary Disorders (COPD) (18.0% vs. 16.6%), Chronic
Renal Failure (CRF) (8.4% vs 5.9%), Chronic Renal Problems (CRP) (8.8% vs. 6.5%), heart
disease (62.5% vs. 51.9%), stroke (17.0% vs. 6.9%), and thyroid disorder (26.1% vs. 22.5%).
Healthcare Behavior: Elderly Medicare beneficiaries with PD had significantly higher rates of
baseline inpatient, outpatient, hospice, skilled nursing facilities, and durable medical equipment
use.
External Environment: An overwhelmingly higher percentage of elderly Medicare beneficiaries
resided in the metro regions in both the two groups (approximately 80% in both groups). Elderly
Medicare beneficiaries in both PD and no PD groups resided primarily in the Southern census
region (around 38% in both groups) followed by Mid-West, North-East and Western regions.
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Table 2 exhibits the relationship between predisposing, enabling, personal health
behavior, need and external environmental factors and home healthcare use by PD status. For
convenience of reading, we only present those with home healthcare use by PD status. There
were 2,445 and 91,971 elderly Medicare beneficiaries with and without PD respectively who had
positive home healthcare use. It was observed that for predisposing, enabling, need, personal
health behavior and external environmental factors, the home healthcare use was statistically
significantly higher among elderly Medicare beneficiaries with PD compared to those without
PD.
Table 3 summarizes the findings from the logistic regression analyses of home healthcare
use in the study sample. It was observed that after controlling for predisposing, enabling, need,
personal health behavior, and external environmental factors, elderly individuals with PD were
greater than two times (Adjusted Odds Ratio: 2.07; 95% Confidence Interval- 1.97-2.17) more
likely to have home healthcare use compared to those without PD.
Table 4 provides the average total and home healthcare of expenditures among those with
home healthcare use. The average total expenditures among elderly Medicare beneficiaries (who
used home healthcare service) with PD ($31,154) was significantly higher compared to those
without PD ($29,465). The average home healthcare expenditures among elderly Medicare
beneficiaries (who used home healthcare service) with PD was 1.34 times higher compared to
those without PD ($6,792 vs. $5,060).
Table 5 presents the results from the OLS regressions on log-transformed home
healthcare expenditures among elderly individuals with and without PD, who had a positive
home healthcare expenditure. Table 5 also provides results from OLS regression on a pooled
sample which included both elderly Medicare beneficiaries with and without PD. The bottom
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panel of Table 5 provides the parameters estimates of the key independent variable of this study
(presence or absence of PD). It can be noted from this part that elderly Medicare beneficiaries
with PD had approximately 37% (calculated using the formula exp(β) - 1) higher home healthcare
expenditure compared to those without PD.
Table 6 shows the results from the non-linear decomposition on the home healthcare use
(yes/no). Elderly Medicare beneficiaries with PD had higher home healthcare use compared to
those without PD (22.50% vs. 9.22%). This translated into a 13.28 percentage point difference
between these two groups in terms of home healthcare use. From the multivariate decomposition
analysis, it was observed that out of the 13.28 percentage point difference in home healthcare use
among elderly Medicare beneficiaries, 3.54 percentage point difference was explained by the
individual level variables included in this study. Thus, approximately 27% difference in home
healthcare use among elderly Medicare beneficiaries with and without PD was explained by the
predisposing, need, personal health choice and external environmental factors. Need
characteristics (physical and mental health conditions) and personal health behaviors (baseline
resource use) of the elderly Medicare beneficiaries explained the highest (approximately 80%)
proportion of the home healthcare use differences between elderly Medicare beneficiaries with
and without PD.
Table 7 displays the results of linear decomposition of home healthcare expenditures
among elderly Medicare beneficiaries with and without PD. These analyses were restricted to
only those who used home healthcare. The mean log-transformed home healthcare expenditures
among elderly Medicare beneficiaries with and without PD was 8.44 and 8.10 units respectively.
This translated into a 0.34 unit difference in mean log-transformed home healthcare
expenditures. Using PD, No PD and pooled weights, the explained portion of the home
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healthcare expenditure differences among elderly Medicare beneficiaries with and without PD
ranged from 10.8%, 7.8% and 7.7% respectively. The remaining majority of the home healthcare
expenditure differences remained unexplained. It was observed that baseline resource use
explained the highest proportion of the home healthcare expenditure differences followed by the
mental health conditions (anxiety and depression). Using the pooled weights, it can be inferred
that ceteris paribus, if the baseline resource use was similar between elderly Medicare
beneficiaries with and without PD, then the log-transformed home healthcare expenditure would
decrease by 0.1 units. The negative coefficient of the predisposing characteristics signifies that if
the gender, race/ethnicity and age characteristics of elderly Medicare beneficiaries with and
without PD were similar, then the difference in log-transformed home healthcare expenditures
would increase by 0.06 units.
DISCUSSION
The present study examined the magnitude of the difference in home healthcare resource
use and expenditures among elderly Medicare beneficiaries with and without PD. This study also
evaluated the extent to which predisposing, enabling, need, personal health behaviors and
external environmental factors explained the differences among elderly Medicare beneficiaries
with and without PD. It was observed that after adjusting for the predisposing, need, personal
health choice and external environmental factors, elderly Medicare beneficiaries with PD had
13.28% and 37% higher home healthcare use and expenditures respectively compared to those
without PD. Previous studies have consistently pointed that home healthcare use and
expenditures among individuals with PD are significantly higher among individuals with PD
((Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein,
Chrischilles, & Voelker, 1997)). However, no study examined the factors associated with higher
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home healthcare use and expenditures among elderly individuals with PD and to what extent the
individual-level factors explain the differences. The unique contribution of this study is to
provide the factors associated with higher home healthcare resource use and expenditures among
elderly Medicare beneficiaries with PD and provide a quantified assessment of the extent to
which these individual-level factors explain the use and expenditures differences using a
nationally representative sample of Medicare beneficiaries.
In terms of resource use, approximately 27% of the 13.28 percentage point differences in
home healthcare use among elderly Medicare beneficiaries were explained by the individuallevel factors adjusted in this study. The remaining 73% unexplained portion can be due to several
factors such as severity and duration of PD, medication adherence and inclination towards
seeking health care. Findings from this study suggest that the need characteristics such as
baseline comorbidities and personal health behavior characteristics such as resource use (apart
from home healthcare) explained the highest proportion of the explained differences. These
findings underscore the importance of developing interventions such as development of
appropriate evidence based co-management of multiple chronic conditions. Moreover, these
findings also suggest that there is a need of collaborative care among different specialists such as
neurologists, endocrinologists, mental health specialists to provide a complete and holistic care
to these elderly individuals with chronic diseases. Integrated Delivery Systems (IDS) where
primary physicians serve as the gate-keeper and maintain a good referral system can also be
helpful in treating elderly individuals with multiple chronic conditions. In the light of recent
Affordable Care Act (ACA), there is an emphasis on team-based approaches such Patient
Centered Medical Home (PCMH) where continuous and well-coordinated care is provided by a
team of healthcare providers
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(http://www.acponline.org/advocacy/state_health_policy/hottopics/pcmh.pdf). The aims of these
PCMHs are to provide evidence based treatments for acute and chronic conditions, as well as
providing preventive services. These types of care models may improve health outcomes of
elderly individuals and hence has the potential to reduce service use and expenditures.
In terms of the home healthcare expenditures among elderly Medicare beneficiaries
having positive home healthcare use, it was observed that only 11% of the differences in home
healthcare were explained by the individual-level factors adjusted in this study. One of the major
reasons of the high unexplained portion may be due to absence of certain variables such as
activities of daily living (ADL), instrumental activities of daily living (IADL), mental and
physical health status. Elderly individuals with PD require high assistance with their daily
activities. Moreover, as the disease progresses, individuals with PD experience higher
impairment in their mental and physical health status, which in turn leads to compromised
quality of life. In a study by Noyes et al. (2006) among Medicare beneficiaries it was observed
that elderly Medicare beneficiaries with PD had significantly higher limitations of ADLs
(average of 2.9 ADLs for individuals with PD vs. 0.8 ADL for individuals without PD)
compared to those without PD that may be attributed to the higher home healthcare use and
expenditures. Due to the limitation of the dataset, this important variable was not adjusted which
may be attributed to the higher unexplained portion.
One of the notable findings from this study is that the mental health conditions,
particularly depression contributed a significant proportion of the explained portion of both home
healthcare use and expenditures. This finding is consistent with a recent study among
community-dwelling elderly individuals with PD, which found that mental health conditions
such as depression and anxiety are the major drivers of higher home healthcare expenditures
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(Bhattacharjee & Sambamoorthi). It has been well documented in the existing literature that
mental health conditions such as depression often leads to psychosocial disabilities as well as
ADL impairment among individuals with PD, which in turn may lead to excess negative health
outcomes (Oluwadamilola et al. 2012). The prevalence of depression in our study sample was
approximately 3 times higher among elderly Medicare beneficiaries with PD compared to those
without PD. Given this high prevalence of depression in the study sample and the associated
negative health outcomes, it is possible that co-occurring depression may lead to higher home
healthcare use and expenditures. Moreover, it is noted that overall, need and personal health
behavior factors explained the biggest proportion of the explained portions in both use and
expenditures.
The study strengths are large sample size, representative sample, and comprehensive list
of variables. While interpreting the findings, the following limitations need to be noted.
Prescription drug expenditures information was not available. The findings from this study are
not generalizable to other populations or setting. Fee-for-service, HMO enrollees are excluded
from the study sample. Users of home healthcare may be different from non-users of home
health care in unobserved variables. Our study does not control for such selection bias. Five
percent Medicare sample will not include many variables that are associated with home
healthcare use. This may lead to underestimation of the explained portion of the estimated
differences in home healthcare expenditures among individuals with and without PD. However,
by using a representative sample of Medicare beneficiaries with linked Medicare claims, we can
estimate the extent to which unmeasured factors can underestimate explained portion of the
differences in expenditures among individuals with and without PD.
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CONCLUSION
Notwithstanding the limitations, this study examined the magnitude of the difference in
home healthcare resource use and expenditures among elderly Medicare beneficiaries with and
without PD and also evaluated the extent to which predisposing, enabling, need, personal health
choice and external environmental factors explained these differences. Elderly individuals with
PD had 13.28% and 37% higher home healthcare use and expenditures compared to those
without PD. Individual-level factors used in this study explained 28% and 10% of the differences
in home healthcare use and expenditures respectively. Future studies should include some of the
factors such as ADL, IADL, and physical and mental health status to understand their influence
on the home healthcare use and expenditures among individuals with PD.
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Table 1: Description of Study Sample by Parkinson’s disease Status
National Medicare 5% Sample - 2006, 2007
Variables
PD
Col %
No PD
Col %
N = 10,865
N = 997,785
Predisposing characteristics
Gender
Female
5,421
49.9
600,932
60.2
Male
5,444
50.1
396,853
39.8
Race/Ethnicity
White
10,007
92.1
891,280
89.3
AA
425
3.9
65,266
6.5
Other
433
4.0
41,239
4.1
Age Group
65-74
3,927
36.1
514,211
51.5
75, +
6,938
63.9
483,574
48.5
Enabling characteristic
Public assistance
Yes
1,742
16.0
113,528
11.4
No
9,123
84.0
884,257
88.6
External Environmental characteristics
Census region
North-East
2,399
22.1
192,983
19.3
Midwest
2,837
26.1
258,335
25.9
South
3,931
36.2
386,457
38.7
West
1,698
15.6
160,010
16.0
Metro status
Metro
8,448
77.8
752,534
75.4
Non-Metro
2,417
22.2
245,251
24.6
Personal Health Behavior
Substance Use
Yes
440
4.0
38,529
3.9
No
10,425
96.0
959,256
96.1
Inpatient visit
Yes
3,584
33.0
185,807
18.6
No
7,281
67.0
811,978
81.4
DME visit
Yes
4,679
43.1
292,847
29.3
No
6,186
56.9
704,938
70.7
Hospice visit
Yes
122
1.1
2,746
0.3
No
10,743
98.9
995,039
99.7
SNF visit
Yes
1,597
14.7
39,780
4.0
No
9,268
85.3
958,005
96.0
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Sig

***

***

***

***

***

***

***

***

***

***

Table 1: Description of Study Sample by Parkinson’s disease Status
National Medicare 5% Sample - 2006, 2007
Variables
PD
Col %
No PD
Col %
Sig
N = 10,865
N = 997,785
***
Office visit quintile
0–5
502
4.6
178,497
17.9
6 – 10
1,335
12.3
225,007
22.6
11 – 16
2,082
19.2
211,344
21.2
17 – 25
2,632
24.2
188,127
18.9
26 – 281
4,314
39.7
194,810
19.5
***
Outpatient visit quintile
0–0
1,708
15.7
251,723
25.2
1-2
1,469
13.5
173,905
17.4
2–3
2,306
21.2
220,167
22.1
4–6
2,234
20.6
168,324
16.9
7 – 178
3,148
29.0
183,666
18.4
Need factors
Anxiety
Yes
No
Arthritis
Yes
No
Cancer
Yes
No
COPD
Yes
No
CRF
Yes
No
CRP
Yes
No
Diabetes
Yes
No
Heart Disease
Yes
No
Hypertension
Yes
No
(Contd.)

***
1,189
9,676

10.9
89.1

58,738
939,047

5.9
94.1

3,679
7,186

33.9
66.1

294,580
703,205

29.5
70.5

1,050
9,815

9.7
90.3

96,972
900,813

9.7
90.3

1,957
8,908

18.0
82.0

165,673
832,112

16.6
83.4

***

***

***
909
9,956

8.4
91.6

59,362
938,423

5.9
94.1
***

951
9,914

8.8
91.2

64,633
933,152

6.5
93.5

2,794
8,071

25.7
74.3

265,381
732,404

26.6
73.4

6,787
4,078

62.5
37.5

518,023
479,762

51.9
48.1

7,743
3,122

71.3
28.7

723,969
273,816

72.6
27.4

*

***

**
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Table 1: Description of Study Sample by Parkinson’s disease Status
National Medicare 5% Sample - 2006, 2007
Variables
PD
Col %
No PD
Col %
Sig
N = 10,865
N = 997,785
***
Major Depression
Yes
2,568
23.6
87,822
8.8
No
8,297
76.4
909,963
91.2
***
Stroke
Yes
1,849
17.0
68,577
6.9
No
9,016
83.0
929,208
93.1
***
Thyroid disorders
Yes
2,837
26.1
224,754
22.5
No
8,028
73.9
773,031
77.5
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s
Disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled
in Health Maintenance organizations during 2006 and 2007; had a positive direct total healthcare expenditures;
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
other reason were excluded from the final sample.
PD: Parkinson‟s disease; SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF:
Chronic Renal Failure; CRP: Chronic Renal Problem; DME: Durable Medical Equipment; HHA: Home Health
Agency; SNF: Skilled Nursing Facility
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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Table 2: Number and Percent with Home Healthcare Use by Parkinson's disease
National Medicare 5% Sample, 2006-2007
PD
% with HHA No PD
% with HHA
Sig
All
2,445
22.5
9,1971
9.2 ***
PD
Col %
No PD
Col %
Predisposing characteristics
Gender
Female
1,348
24.9
62,687
10.4 ***
Male
1,097
20.2
29,284
7.4 ***
Race/Ethnicity
White
2,202
22.0
78,889
8.9 ***
African Americans
135
31.8
8731
13.4 ***
Other
108
24.9
4351
10.6 ***
Age Group
65-74
679
17.3
28,962
5.6 ***
75, +
1,766
25.5
63,009
13.0 ***
Enabling characteristics
Public Assistance
Yes
392
22.5
17,576
15.5 ***
No
2,053
22.5
74,395
8.4 ***
External Environmental characteristics
Census region
North-East
562
23.4
19,581
10.1 ***
Midwest
529
18.6
20,225
7.8 ***
South
1,031
26.2
40,320
10.4 ***
West
323
19.0
11,845
7.4 ***
Metro status
Metro
1,986
23.5
72,296
9.6 ***
Non-Metro
459
19.0
19,675
8.0 ***
Personal Health Behaviors
SUD
Yes
126
28.6
5,580
14.5 ***
No
2,319
22.2
86,391
9.0 ***
Outpatient Visits Quintile
0–0
313
18.3
16,557
6.6 ***
1-1
303
20.6
13,330
7.7 ***
2–3
514
22.3
19,008
8.6 ***
4–6
545
24.4
17,200
10.2 ***
7 - 178
770
24.5
25,876
14.1 ***
Office visit quintile
0–5
72
14.3
8,163
4.6 ***
6 - 10
206
15.4
12,666
5.6 ***
11 - 16
372
17.9
16,418
7.8 ***
17 - 25
570
21.7
20,086
10.7 ***
26 - 281
1,225
28.4
34,638
17.8 ***
(Contd.)
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Table 2: Number and Percent with Home Healthcare Use by Parkinson's disease
National Medicare 5% Sample, 2006-2007
PD
% with HHA No PD
% with HHA
Sig
All
2,445
22.5
9,1971
9.2 ***
PD
Col %
No PD
Col %
Need factors
Anxiety
Yes
334
28.1
8,594
14.6 ***
No
2,111
21.8
83,377
8.9 ***
Arthritis
Yes
1,024
27.8
41,726
14.2 ***
No
1,421
19.8
50,245
7.1 ***
Cancer
Yes
278
26.5
11,475
11.8 ***
No
2,167
22.1
80,496
8.9 ***
COPD
Yes
569
29.1
25,518
15.4 ***
No
1,876
21.1
66,453
8.0 ***
CRF
Yes
270
29.7
11,376
19.2 ***
No
2,175
21.8
80,595
8.6 ***
CRP
Yes
293
30.8
11,462
17.7 ***
No
2,152
21.7
80,509
8.6 ***
Diabetes
Yes
725
25.9
33,506
12.6 ***
No
1,720
21.3
58,465
8.0 ***
Diabetic Nephropathy
Yes
41
30.4
2,232
19.6 **
No
2,404
22.4
89,739
9.1 ***
Heart disease
Yes
1,714
25.3
64,601
12.5 ***
No
731
17.9
27370
5.7 ***
Hypertension
Yes
1,892
24.4
76,422
10.6 ***
No
553
17.7
15,549
5.7 ***
Depression
Yes
684
26.6
14,613
16.6 ***
No
1,761
21.2
77,358
8.5 ***
Stroke
Yes
538
29.1
13,148
19.2 ***
No
1,907
21.2
78,823
8.5 ***
Thyroid disorder
Yes
736
25.9
25,900
11.5 ***
No
1,709
21.3
66,071
8.5 ***
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled
in Health Maintenance organizations during 2006 and 2007; had a positive direct total healthcare expenditures;
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
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other reason were excluded from the final sample. For ease of reading, percentage without home healthcare use by
Parkinson‟s disease status is not presented.
Asterisks represent significant group differences by Parkinson‟s disease status based on chi-square tests.
SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure;
CRP: Chronic Renal Problem; DME: Durable Medical Equipment; HHA: Home Health Agency; SNF: Skilled
Nursing Facility
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals
from Logistic Regression on Home Healthcare Use
National Medicare 5% sample, 2006-2007
AOR
Parkinson's disease
Yes

2.07

95% CI

Sig

[1.97,2.17]

***

No
Predisposing characteristics
Gender
Female

1.30

[1.28,1.32]

***

African American

1.35

[1.31,1.38]

***

Others

1.04

[1.00,1.08]

*

2.21

[2.18,2.25]

***

Male
Race/Ethnicity
White

Age Group
75, +
65-74

Enabling characteristics
Public Assistance
Yes

1.34

[1.31,1.36]

***

No
External Environmental characteristics
Census
Region
North-East

1.28

[1.25,1.31]

***

Midwest

1.04

[1.02,1.07]

***

South

1.42

[1.39,1.45]

***

1.20

[1.18,1.22]

***

West
Metro status
Metro
Non-metro
Personal Health Behavior
SUD
Yes

1.19

[1.15,1.23]

***

Outpatient visit quintile
0–0

0.93

[0.91,0.95]

***

1-1

0.94

[0.92,0.97]

***

2-3

0.94

[0.92,0.96]

***

4-6

0.96

[0.94,0.98]

***

No

7 - 178
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals
from Logistic Regression on Home Healthcare Use
National Medicare 5% sample, 2006-2007
AOR

95% CI

Sig

0.70

[0.68,0.72]

***

6 - 10

0.68

[0.67,0.70]

***

11 - 16

0.77

[0.75,0.79]

***

17 - 25

0.86

[0.84,0.88]

***

SNF visits

0.95

[0.94,0.96]

***

Inpatient visits

1.31

[1.30,1.32]

***

Hospice visits

0.98

[0.97,0.99]

***

DME visits

1.05

[1.05,1.05]

***

Office visit quintile
0-5

26 - 281

Need characteristics
Anxiety
Yes

1.04

[1.01,1.07]

**

1.50

[1.48,1.53]

***

1.03

[1.01,1.06]

**

1.13

[1.11,1.15]

***

1.17

[1.14,1.20]

***

1.11

[1.08,1.14]

***

1.17

[1.15,1.19]

***

1.13

[1.07,1.19]

***

No
Arthritis
Yes
No
Cancer
Yes
No
COPD
Yes
No
CRF
Yes
No
CRP
Yes
No
Diabetes
Yes
No
Diabetic Nephropathy
Yes
No

(Contd.)
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals
from Logistic Regression on Home Healthcare Use
National Medicare 5% sample, 2006-2007
AOR
Heart disease
Yes

95% CI

Sig

1.29

[1.27,1.31]

***

1.10

[1.08,1.13]

***

1.22

[1.19,1.25]

***

1.32

[1.29,1.35]

***

1.02

[1.00,1.03]

No
Hypertension
Yes
No
Depression
Yes
No
Stroke
Yes
No
Thyroid disorder
Yes
No
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s
Disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled
in Health Maintenance organizations during 2006 and 2007; had a positive direct total healthcare expenditures;
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
other reason were excluded from the final sample.
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; CI: Confidence Intervals; SUD: Substance Use Disorder;
COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure; CRP: Chronic Renal Problem;
DME: Durable Medical Equipment; SNF: Skilled Nursing Facility
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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Table 4: Average Total and Home Healthcare Expenditures among Home Healthcare
Users
Elderly Individuals with and without PD
National Medicare 5% sample, 2006,2007
PD
N = 2,445
Average

No PD
N = 91,971

Std. Dev

Average

Std. Dev

Total**

31,154

27,249

29,465

27,107

HHA***

6,792

6,640

5,060

5,849

21.8%
17.2%
% spent on Home Healthcare
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled
in Health Maintenance organizations during 2006 and 2007; had a positive direct home healthcare expenditures;
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
other reason were excluded from the final sample. For ease of reading, percentage without home healthcare use by
Parkinson‟s disease status is not presented.
Group differences determined using t-test
*** p < .001; **.001 ≤ p < .01;
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Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression
on Log-transformed Home Healthcare Expenditures
National Medicare 5% Sample - 2006, 2007
PD
Intercept

No PD

Pooled

Beta

S.E.

Sig

Beta

S.E.

Sig

Beta

S.E.

Sig

8.082

0.102

***

7.729

0.018

***

7.730

0.018

***

***

0.095

0.007

***

***
0.016 ***

0.240

0.011

***

0.164

0.016

***

***

-0.164

0.007

***

***

0.182

0.009

***

***

-0.068

0.011

***

***
0.010 ***

-0.141

0.011

***

0.168

0.010

***

0.070

0.008

***

Predisposing characteristics
Gender
Female

0.076

0.041

0.096

0.007

AA

0.166

0.087

0.241

0.011

Other

0.086

0.100

0.166

-0.086

0.044

0.166

Male
Race/Ethnicity
White

Age group
65-74 years

0.007

75, + years
Enabling characteristic
Public assistance
Yes

0.110

0.057

0.184

0.009

No
External environmental characteristics
Census region
Midwest

-0.065

0.069

North-East

-0.095

0.067

0.171

0.062

0.095

0.052

South

**

0.068
0.142
0.167

0.011
0.011

West
Metro status
Metro

0.069

0.008

***

Non-Metro
Need factors- Baseline comorbidities and resource use
Anxiety
Yes

-0.003

0.060

0.006

0.011

0.063

0.041

0.094

0.007

-0.006

0.011

0.093

0.007

No
Arthritis
Yes

***

No
(Contd.)
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***

Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression
on Log-transformed Home Healthcare Expenditures
National Medicare 5% Sample - 2006, 2007
PD
Beta

S.E.

-0.083

No PD
Sig

Pooled

Beta

S.E.

Sig

Beta

S.E.

Sig

0.062

0.053

0.010

***

-0.054

0.010

***

-0.047

0.049

0.040

0.008

***

-0.040

0.008

***

0.005

0.070

0.016

0.011

0.016

0.011

-0.078

0.066

0.010

0.011

0.008

0.011

-0.009

0.045

0.075

0.007

***

0.072

0.007

***

Diabetic Nephropathy
Yes
0.299

0.158

0.087

0.022

***

0.091

0.021

***

0.052

0.048

0.043

0.008

***

0.043

0.008

***

0.012

0.050

0.010

0.009

0.009

0.009

Major Depressive Disorder
Yes
0.035

0.047

0.095

0.009

***

0.094

0.009

***

-0.025

0.049

0.153

0.009

***

0.146

0.009

***

-0.035

0.044

0.019

0.007

**

0.018

0.007

*

Cancer
Yes
No
COPD
Yes
No
CRF
Yes
No
CRP
Yes
No
Diabetes
Yes
No

No
Heart disease
Yes
No
Hypertension
Yes
No

No
Stroke
Yes
No
Thyroid Disorder
Yes
No
(Contd.)
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Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression
on Log-transformed Home Healthcare Expenditures
National Medicare 5% Sample - 2006, 2007
PD
Beta

S.E.

No PD
Sig

Beta

Pooled

S.E.

Sig

Beta

S.E.

Sig

-0.034

0.014

*

0.053

0.010

***

Personal Health Choices
SUD
-0.117

0.089

0.031

0.014

*

Outpatient Visit Quintile
0–0
0.056

0.069

0.053

0.011

***

Yes
No

1-1

0.083

0.067

0.016

0.011

0.018

0.011

2-3

0.020

0.056

0.009

0.010

0.009

4-6

0.053

0.054

0.010
0.029

0-5

-0.275

0.126

6 - 10

-0.068

0.082

11 - 16

-0.022

0.064

17 - 25

-0.079

0.052

Other Resource Utilizations
SNF visits
0.033

0.017

0.010

**

-0.027

0.009

**

0.014

**

-0.047

0.014

***

0.012

***

-0.051

0.011

***

0.010

***

-0.043

0.010

***

0.009

***

-0.048

0.009

***

***
0.003 ***
0.005 ***
0.000 ***

0.059

0.004

***

0.024

0.003

***

0.027

0.005

***

0.017

0.000

***

0.020

***

7 - 178
Office Visit Quintiles
*

0.044
0.050
0.044
0.047

26 - 281

Inpatient visits

0.082

0.018

Hospice visits

0.024

0.027

DME visits

0.015

0.003

0.061
***

0.022
0.027

***

0.017

0.004

Pooled regression coefficient for the presence or absence of PD
Parkinson's Disease
Yes

0.313

No
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled
in Health Maintenance organizations during 2006 and 2007; had a positive direct home healthcare expenditures;
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
other reason were excluded from the final sample.
SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure;
CRP: Chronic Renal Problem; DME: Durable Medical Equipment; SNF: Skilled Nursing Facility
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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Table 6: Non-Linear decomposition of baseline home healthcare use
among elderly
Medicare beneficiaries with and without PD
Multivariate Decomposition of Non-Linear dependent variable
Medicare 5% claims database (2006, 2007)
Weights
(in percentage points)
Pooled

Variables

Predisposing characteristics
gender, race/ethnicity, age

0.008

Enabling characteristic
Public assistance

-0.002
Need characteristics

Physical health conditions
0.0038
Mental health conditions (anxiety,
0.002
depression)
Personal Health choices
Any type of SUD

0.00002

Baseline resource use

0.0235
External environment

Census region, metro-status
Total explained
Unexplained portion

0.0001
0.0354
0.09746

Percentage explained
26.64%
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without PD
Difference in home healthcare use = 13.28 percentage points. Percentage points in home healthcare use are
explained by each independent variable. The percentage explained is derived by dividing the total explained portion
by the 13.28 percentage point difference between elderly Medicare beneficiaries with and without PD.
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Table 7: Linear decomposition of logged home healthcare expenditures among elderly
Medicare beneficiaries with and without PD
Blinder-Oaxaca Linear Decomposition Technique
Medicare 5% claims database (2006, 2007)
Weights
(in percentage points)
Pooled
PD
No PD

Variables
Predisposing characteristics
gender, race/ethnicity, age

-0.05

-0.039

-0.048

Enabling characteristic
Public assistance

-0.016

-0.009

-0.017

Need characteristics
Physical health conditions
0.014
0.003
0.013
Mental health conditions (anxiety, depression)
0.032
0.012
0.033
Personal Health choices
Any type of SUD
0.0009
0.003
0.0008
Baseline resource use
0.105
0.143
0.105
External environment
Census region, metro-status
-0.009
-0.005
-0.009
0.077
0.108
0.078
Total explained
0.923
0.892
0.922
Unexplained portion
Percentage explained
7.7% 10.8%
7.8%
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without PD who had a
positive home healthcare expenditures
lnexp (PD) = 8.44 and lnexp (No PD) = 8.10; total difference = 0.34
SUD: Substance Use Disorder
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CHAPTER 3: Parkinson’s disease and Burden on Informal Caregivers: Results from the
National Alliance of Caregiving Survey

INTRODUCTION
Parkinson‟s disease (PD), the second most common neurodegenerative disease, is
characterized by motor and non-motor symptoms (Muangpaisan, Mathews, Hori, & Seidel,
2011). With the progression of PD, the motor (rigidity, postural instability, resting tremors) and
non-motor (loss of smell, visual hallucinations, sleep disorders) symptoms worsen leading to
severe disability (Muangpaisan et al., 2011; Park & Stacy, 2009). In addition to motor and nonmotor symptoms, individuals with PD also exhibit cognitive impairment and behavioral issues
(Lau & Au, 2011). Due to movement difficulties and cognitive decline, individuals with PD
frequently experience limitations in activities of daily living (ADLs) well as instrumental
activities of daily living (IADLs) (Cahn et al., 1998; Noyes, Liu, Li, Holloway, & Dick, 2006;
Whetten-Goldstein, Sloan, Kulas, Cutson, & Schenkman, 1997). It has been estimated that up to
two-thirds of elderly individuals with PD experience ADL and IADL difficulties (Noyes et al.,
2006; Whetten-Goldstein et al., 1997).
Parkinson’s disease and Informal Caregivers
Because of limitations of ADLs, IADLs, motor and non-motor symptoms, cognitive
impairment and behavioral issues individuals with PD rely on formal and informal caregivers for
performing their daily activities (Noyes et al., 2006; Whetten-Goldstein et al., 1997). An
overwhelming majority (as high as 78%) of individuals with PD relied on their caregivers for
ADL/IADL activities (Noyes et al., 2006; Whetten-Goldstein et al., 1997). As majority of elderly
individuals with PD live in communities, caregiving is mainly provided by spouse or children of
individuals with PD (Lau & Au, 2011). A meta-analysis found that majority (86.4%) of the
caregivers of PD were spouses, and 10.1% of the caregivers were adult children of individuals
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with PD (Lau & Au, 2011). When caregiving is provided by close family members, relatives, or
friends who do not have any organizational affiliations or certificates for caregiving they are
considered as informal caregivers (Rakoski et al., 2012). It has been estimated that in the U.S
65.7 million adult individuals provide informal caregiving to individuals who are ill, disabled or
aged [The National Alliance for Caregiving and AARP (2009), Caregiving in the U.S. National
Alliance for Caregiving. Washington, DC.] and 43.5 million adult caregivers provide care for
older individuals (age ≥ 50 years). According to the American Time Use Survey in 2011, an
estimated average of 3.12 hours per day was spent in providing informal care to elderly
individuals for several different activities such as eating, drinking, managing funds, grocery
shopping, and other household activities etc. (http://www.bls.gov/news.release/atus.htm).
Parkinson’s disease and Informal Caregiver Burden
Although caregiving is a part of life, providing care to individuals with chronic illness,
functional limitations, and cognitive decline can be burdensome. This is because providing care
to these individuals can be highly stressful as caregiving involves fear or uncertainty, shift in
roles, financial burden, social isolation, little time alone, demands of constant care and feel of
guilt
(http://www.wfmh.org/PDF/Caring%20for%20the%20Caregiver%2011_04_09%20FINAL%20
%283%29.pdf). Moreover, with the increase in severity of the illness, caregivers have to
undertake new and increased burdensome responsibilities, which generally lead to elevated
levels of psychological, emotional, financial and physical burden of caregivers (Sanders-Dewey,
Mullins, & Chaney, 2001; Whetten-Goldstein et al., 1997).
In concept, caregiver burden is defined as “the strain or load borne by a person who
cares for an elderly, chronically ill, or disabled family member or other person. . . . the point
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where the experience is no longer a viable or healthy option for either the caregiver or the
person receiving care” (Kasuya, Polgar-Bailey, & Takeuchi, 2000). However, in practice it is
challenging to precisely measure informal caregiver burden. Caregiver burden is often measured
by Zarit Burden Inventory, which is a 22-item caregiver-reported scale or a visual analogue scale
(VAS) known as Caregiver Distress Scale. ZBI measures many aspects of caregiver burden
including emotional and physical health of the caregivers, financial issues of the caregivers, the
impact of caregiving on their social life (Seng et al., 2010). Caregiver Distress Scale measures
caregiver stress on a scale of zero to ten with zero indicating no stress and 10 indicating
overwhelming stress (Cifu et al., 2006). Simpler measures have been used in the existing
literature. Some studies have measured the caregiver burden by the number of hours spent on
caregiving and the costs associated with it (Parrish, Giunta, & Adams, 2003; Rakoski et al.,
2012).
Informal caregiving is especially burdensome among caregivers of individuals with PD.
Evidence of this association comes mainly from studies that have been conducted in international
settings. Studies conducted in different countries (Korea, Denmark, Norway, Ireland, Sweden,
Spain, Brazil, Australia, Italy, and United Kingdom) have shown that the informal caregiver
burden of those caring for individuals with PD was higher as compared to the caregiver burden
of individuals caring for individuals with other chronic disease conditions (D'Amelio et al., 2009;
Hounsgaard, Pedersen, & Wagner, 2011; Kim et al., 2007; Lökk, 2009; Lökk, 2009; MartínezMartín et al., 2005; O'Connor & McCabe, 2011; O'Reilly, Finnan, Allwright, Smith, & BenShlomo, 1996; Peters, Fitzpatrick, Doll, Playford, & Jenkinson, 2011; Stella, Banzato, Quagliato,
Viana, & Christofoletti, 2009; Thommessen et al., 2002). In one study conducted in Korea, it
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was observed that caregivers of individuals with PD experienced higher burden of caregiving
compared to other general chronic diseases (Kim et al., 2007).
Only a handful of studies have evaluated the informal caregiver burden among those
providing care to individuals with PD in the U.S. (Carter, Stewart, Lyons, & Archbold, 2008;
Cifu et al., 2006; Edwards & Ruettiger, 2002; Parrish et al., 2003). According to a 1999 study of
324 informal caregivers of individuals with PD in California area, it was reported that informal
caregivers provided an estimated average of 96 hours/week, caring for individuals with PD
(Parrish et al., 2003). In addition, a majority (over 70%) of caregivers suffered ADLs (eating,
dressing, toileting, transferring), IADLs (taking medication), and other health related issues due
to caregiving. Informal caregiver burden is also associated with many factors. One study
conducted among 41 caregivers of individuals with PD in six Midwestern states of U.S. showed
that greater assistance with ADLs was significantly associated with caregiver burden (Edwards
& Ruettiger, 2002). Using data from 49 caregivers of individuals with PD from the Parkinson‟s
disease Research, Education, and Clinical Center (PADRECC) in Richmond, Virginia, U.S., it
was found that caregiver burden increased when individuals with PD had greater levels of
difficulty in performing ADLs (Cifu et al., 2006). Another study using data from an 8-year
clinical trial DATATOP, found that among 219 caregivers of individuals with PD, clinical
symptoms of PD, depression, motor and non-motor psychological symptoms were associated
with caregiver burden (Carter et al., 2008).
Need for the study
Although these studies evaluated informal caregiver burden among individuals with PD,
they are limited by geographical locations within the U.S. (Edwards & Ruettiger, 2002) and
small sample size (Cifu et al., 2006). Many of these studies are outdated with data from as early
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as1999 (Parrish et al., 2003). Additionally, none of these studies estimated costs associated with
informal caregiving among caregivers of individuals with PD. Furthermore, according to the
Administration on Aging of the Department of Health and Human Services, by 2030 there will
be an estimated 72.1 million elderly individuals (age ≥ 65 years) as compared to 39.6 million
elderly individuals in 2009 (http://www.aoa.gov/Aging_Statistics/). Similarly, the number of
individuals with PD is expected to rise two-fold by 2030 (Park & Stacy, 2009). This growth in
the number of individuals with PD has implications for caregiving burden and costs associated
with informal caregiving. In this context, it is important to identify caregivers who are at high
risk for high care burden so that programs and interventions can be developed to improve the
well-being of the caregivers.
Therefore, the primary objective of the current study was to estimate the extent of
caregiver burden and costs associated with informal caregiving and examine factors associated
with such burden among caregivers of individuals with PD. For purposes of the current study, we
used a nationally representative data from the National Alliance of Caregiving, American
Association of Retired Persons (NAC/AARP) survey using 2004 and 2009 data.
Conceptual Framework
The conceptual framework used for this study was the Stress-Process Model developed
by Conde-Sala et al. (2010). According to this frame-work, different factors associated with the
burden of caregiving are: (i) Contextual variables which encompasses socio-demographic factors
of both care-recipients and caregivers as well as factors associated with caregiving; (ii) primary
stressors such as the progression of the disease or symptoms of patients; and (iii) secondary
stressors which constitutes caregiving related factors which leads to difficulties in different
settings such as family, work or financial (Conde-Sala et al. 2010). One of the advantages of this
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model is that it utilizes a multidimensional perspective on the factors associated with caregiving
burden and takes into account both observed and conceptual aspects (Kim et al. 2012). We used
a modified version of this conceptual model as some of the variables are not available due to
limitations of the dataset.
Figure 1: Stress Process Model

Contextual variables
Sociodemographic
factors of
care-recipients

Sociodemographic
factors of
caregivers

Caregiving
related
factors

Primary stressors
Patient symptomatology
Disease progressions

Secondary stressors
Family conflicts
Difficulties at work
Financial difficulties

Caregiver symptoms:
Burden

Social Support
Education (skills)
Emotional (coping)
Family associations

Isolation

Anxiety

Social resources
Domiciliary
Community
Institutional
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Physical health

Treatments/
Interventions

Highlighted parts were examined in this study
Model adapted from Conde-sala et al. (2010): Conde-Sala J.L., Garre-Olmo J., Turro-Garriga O.,
Vilalta-Franch J. & Lopez-Pousa S. (2010). Differential features of burden between spouse and
adult-child caregivers of patients with Alzheimer‟s disease: an exploratory comparative design.
International Journal of Nursing Studies 47(10), 1262–1273.
METHODS
Study Design
We adopted a retrospective cross-sectional study design with observational data.
Data Source: National Alliance for Caregiving (NAC)
We used multiple years (2004, 2009) of data from the National Alliance for Caregiving,
American Association of Retired Persons (NAC/AARP) survey. The nationwide survey data
were collected by NAC/AARP by using a random digit dialing on the basis of surname. For the
NAC data collected in 2004, 6,139 adults (age ≥ 18 years) residing in the US were interviewed,
and 6,806 adult individuals within US were interviewed for the data collected in 2009. The
survey design of NAC included oversampling of minorities to attain a total of 200 African
American caregivers, 200 Hispanic caregivers, and 200 Asian caregivers (NAC/AARP 2004c;
NAC/AARP 2009c). The national random digit dialing (RDD) was stratified by geographical
location in order to obtain a set of telephone numbers that were proportionate to the population
of that area. The survey consisted of 1,247 and 1,397 caregivers for 2004 and 2009 NAC survey
data (NAC/AARP 2004a; NAC/AARP 2009a).
Study Sample
The study sample consisted of elderly care-recipients aged 65 years or older. The carerecipients were categorized as individuals with (i) PD and (ii) no PD.
Individuals who provided help with at least one activity of daily living or instrumental
activity of daily living were classified as informal Caregivers (Kim et al. 2012). The question in
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the survey that helped to classify caregivers was “In the last 12 months, has anyone in your
household provided unpaid care to a relative or friend 50 years or older to help them take care
of themselves? Unpaid care may include help with personal needs or household chores. It might
be managing a person's finances, arranging for outside services, or visiting regularly to see how
they are doing. This person need not live with you.” Pooling data from 2004 and 2009 NAC
survey, we had 32 caregivers who provided care to elderly care-recipients with PD and 1,639
caregivers who provided care to other elderly care-recipients without PD meeting the study
inclusion criteria. The complex multistage sampling design of NAC survey was adjusted by
incorporating the survey weights in the SAS survey statistical procedures, such as
SURVEYFREQ and SURVEYMEANS. The SURVEYREG procedure was used to conduct the
Ordinary Least Square (OLS) regression analysis by adjusting for complex survey design.
Data Collection/Field Methodology
The nationally representative data was collected via telephone interviews. After
establishing telephone contact, the interviewer asked to speak to an individual in the household
who had the most-recent birthday and were 18 years or older. If the initial respondent was not the
caregiver, then the interviewer requested to speak to the caregiver and only one caregiver from
each household was interviewed. Household information, demographic information as well as
other appropriate data on both caregivers and care-recipients was collected in the NAC survey.
The interview was terminated in the cases where the randomly selected primary respondent
stated that there was no caregiver in the household (NAC/AARP 2004c; NAC/AARP 2009c).
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Approvals
NAC/AARP approved the use of the anonymous and de-identified survey data. The
Institutional Review Board (IRB) of West Virginia University approved this study before the
initiating the data analysis.
Dependent Variables
Caregiver burden
Caregiver burden was measured based on three questions on physical strain (“How much
of a physical strain caring for recipient is/was for you?”), emotional stress (“How emotionally
stressful caring for recipient is/was for you?”) and financial hardship (“How much of a financial
hardship caring for recipient is/was for you?”). Responses from these three questions on a scale
from 1 to 5 (1 = not at all strain/stress/hardship; 2 = , 3 = , 4= , 5 = very high
strain/stress/hardship) were used to develop caregiver burden measure (Kim et al. 2012). Factor
analysis using Principal Component Analysis showed one factor solution and the reliability
analysis revealed high Cronbach‟s alpha value (Cronbach‟s alpha for PD sample = 0.74,
Cronbach‟s alpha for No PD sample = 0.72). Therefore, a composite scale was developed by
calculating the mean of the three items, where a score of 1 and 5 indicated lowest and highest
caregiver burden respectively. This method is validated in the existing literature (Kim et al.
2012).
Key Independent Variable
The key independent variable for this study was care-recipients‟ presence or absence of
PD. Identification of individuals with PD was based on the question in the survey which queried
what was the “Main problem or illness recipient has/had” for which caregiving was provided.
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Other Independent Variables
Characteristics of care-recipients
The characteristics of care-recipients that were included in this study were: age, sex
(male/female), living situation (lives in caregiver household, lives elsewhere), number of
activities of daily living (ADLs) limitations, number of instrumental activities of daily living
(IADLs) limitations. The six items of ADLs comprised of (a) eating; (b) dressing; (c) bathing;
(d) toileting; (e) mobility inside own house; and (f) getting in and out of bed. IADLs consisted of
five activities: (i) grocery shopping; (ii) cooking; (iii) managing money; (iv) taking medications;
and (v) using the telephone. Number of ADLs and IADLs were used for the purpose of analysis.
Characteristics of caregivers
Characteristics of caregivers consisted of age, sex (male/female), and marital status
(married, unmarried living with others, unmarried living alone).
Other independent variables
Other independent variables consisted of number of hours of caregiving per week and
presence or absence of paid caregivers.
Cost associated with informal caregiving
Costs associated with informal caregiving were calculated by multiplying hours spent on
informal caregiving by informal caregivers with the estimated market wage rate of a paid
caregiver (Rakoski et al., 2012). Annual costs were estimated by multiplying each caregiver‟s
weekly hours of informal caregiving by 52 and the median hourly wage for a home health aide
(US$10.10) (Rakoski et al., 2012) (http://www.bls.gov/oes/current/oes311011.htm). The 10th and
90th percentile of the cost associated with informal caregiving was also estimated using the
respective hourly wage value of a home health aide ($8.03 and $14.17 for 10th and 90th percentile
respectively).
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Sub-group/Sensitivity Analysis
Sub-group analysis was conducted by comparing caregiver burden among caregivers of
elderly care-recipients with PD to those with Alzheimer's disease, confusion, dementia, and
forgetfulness.
Statistical Analyses
Unadjusted differences in caregiver burden among care-recipients with and without PD
were determined by using t-tests. Multiple linear regressions were conducted to compare
caregiver burden and costs after adjusting for care-recipient, caregiver characteristics and other
independent variables (age of caregiver, sex of caregiver, caregiver marital status, living
situation of care-recipient, ADLs, IADLs, presence or absence of paid caregiver, and the number
of hours of caregiving provided per week). Three OLS regression analyses were conducted,
which utilized informal caregiver burden, number of hours per week of caregiving, and logtransformed informal cost of caregiving. The cost of informal caregiving was logarithmically
transformed for the multiple OLS model as the cost data are generally skewed. Dependent
variable and the independent variables adjusted in the final multivariate analysis were checked
for missing data, and none of the variables had missing values of more than 5%. Nationally
representative data were generated by adjusting for population weights in the bivariate and
multivariate analyses. In the NAC/AARP survey, the population weights were calculated on the
basis of subset of totally screened respondents in the base study who constituted the original
individuals who were randomly selected. A single-stage weighting procedure was used to
achieve the nationally representative estimates. All analyses will be conducted using SAS 9.3
(SAS Institute, Cary, NC).
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RESULTS
Table 1 displays the care-recipient and caregiver characteristics by presence or absence of
PD.
Sample description by care-recipient characteristics
The mean age of care-recipients with PD was 81.29 (± 6.53) years, while the mean age of carerecipients without PD was 80.69 (± 8.17). The mean score of ADLs among care-recipients with
and without PD were 3.14 (± 2.02) and 1.71 (± 1.96) respectively. Care-recipients with PD had a
mean IADL score of 4.82 (± 2.01), whereas those without PD had a mean score of 4.41 (± 1.84).
Majority of the care-recipients with (55.8%) and without (68.7%) PD was females.
Sample description by caregiver characteristics
In terms of the caregivers, the mean age of caregivers for care-recipients with and
without PD was 55.03 (± 14.19) years and 52.05 (± 14.35) years respectively. Majority of the
caregivers for care-recipients (51.8%) with PD were male, whereas majority of caregivers
(59.8%) for care-recipients for those without PD were females. Nearly two-thirds of caregivers
of care-recipients with (67.6%) and without PD (61.3%) were married. Majority of the carerecipients in both groups lived in places other than the caregiver‟s house.
Other Independent Variables
The mean number of caregiving hours per week reported by caregivers of care-recipients
with and without PD was 27.51 (± 35.04) hours and 21.62 (± 28.71) hours respectively. Majority
of the care-recipients with (51.9%) and without (54%) PD did not have a paid caregiver.
Table 2 summarizes the unadjusted group differences in caregiver burden by caregiver
characteristics.
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Unadjusted group differences by care-recipient characteristics
Statistically significant differences in caregiver burden were observed by sex of
caregiver, marital status of caregiver, care-recipient‟s residency status, functional status (ADL
and IADL), as well as by the presence or absence of a paid caregiver. It was observed that male
caregivers of care-recipients with PD (2.5 ± 0.25) had higher mean caregiver burden compared to
the male caregivers of care-recipients without PD (2.02 ± 0.04). Married caregivers of carerecipients with PD (2.31 ± 0.23) reported a significantly higher average caregiver burden than
the married caregivers of care-recipients without PD (2.1 ± 0.04). As expected, higher the
functional limitations (ADL and IADL) of care-recipients, higher were the reported mean
caregiver burden. Average number of hours per week of informal caregiving was substantially
higher among caregivers of care-recipients with PD, who resided within the same household as
the caregivers as compared to those living elsewhere (55.5 ± 12.27 vs. 12.72 ± 4.3). With the
increase in the number of functional limitations (ADL and IADL), the number of hours of
informal caregiving per week also increased significantly in both the groups. Similar findings
were observed with the annual informal cost of caregiving.
Table 3 shows the findings from multiple linear regressions. These regressions were
adjusted for survey weights. Three multiple linear regression analyses were conducted, which
utilized caregiver burden, number of hours per week of caregiving, and log-transformed informal
cost of caregiving. Factors that were adjusted in analysis that used caregiver burden as the
dependent variable were presence or absence of PD, age of caregiver, sex of caregiver, marital
status of caregiver, functional status (ADLs and IADLs), presence or absence of a paid caregiver,
hours per week of informal caregiving and the whether the care-recipient was staying within or
outside the caregiver house. For the analyses that used number of hours per week of informal
caregiving and the log-transformed informal cost of caregiving, the factors that were adjusted
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included presence or absence of PD, age of caregiver, sex of caregiver, marital status of
caregiver, functional status (ADLs and IADLs), presence or absence of a paid caregiver and the
whether the care-recipient was staying within or outside the caregiver house. It was observed that
in all the three different regression analyses, caregiver burden did not differ by the presence or
absence of PD. ADLs and IADLs were consistently positively associated with caregiver burden
in all the three models. Female caregivers were also found to be significantly more likely to
experience higher caregiving burden compared to male caregivers in all the three models.
Cost associated with informal caregiving
The median wage of a home health aide ($10.10) for 2013 was obtained from the Bureau
of Labor Statistics. Using this median wage and the mean number of hours of caregiving (Table
1), the national yearly informal cost of caregiving for care-recipients with and without PD was
estimated to be approximately $14,450 and $11,360 respectively. The 10th and 90th percentile
hourly wage value of a home health aide are $8.03 and $14.17 respectively. Using this wage
values, the national yearly informal caregiving costs ranged between $11,500 and $20,300 for
care-recipients with PD, while that of care-recipients without PD ranged between $9,050 and
$16,000 (all wage values rounded up).
Sub-group/Sensitivity analysis
Sub-group analysis was conducted by comparing the caregiver burden among caregivers
of care-recipients with PD and those with Alzheimer's disease, confusion, dementia, and
forgetfulness. After adjusting for all the care-recipient, caregiver and other independent
variables, it was observed that the caregiving burden did not differ between these two groups (β
= -0.25, p = 0.1091).
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DISCUSSION
Using a nationally representative sample of caregivers in the United States (U.S.), the
present study examined the informal caregiver burden and cost associated with caregiver burden
among care-recipients with and without PD. To the best of author‟s knowledge, this is the first
nationally representative study comparing informal caregiving burden and costs among carerecipients with and without PD. The study hypothesized that, informal caregiving burden will be
higher among those who provided care to elderly individuals with PD compared to caregivers of
elderly without PD, due to special needs of elderly individuals with PD in terms of limitations of
ADLs, IADLs, motor and non-motor symptoms, cognitive impairment and behavioral issues
(Noyes et al., 2006; Whetten-Goldstein et al., 1997). However, findings from this nationally
representative study revealed that there were no significant differences in caregiving burden
among caregivers of care-recipients with and without PD. Although the caregivers of elderly
individuals with PD spent 1.4 times more hours in providing informal care compared to
caregivers of elderly without PD, the difference was not statistically significant. This lack of
statistical significance could be due to the small sample size of the care-recipients with PD. For
example, post-hoc power analysis revealed that a minimum of 373 elderly individuals in each
group will be needed to detect a statistically significant difference.
A noteworthy finding in our study is the association between the functional status of the
care-recipients and caregiver burden. It was observed that ADL and IADL were significantly
positively associated with caregiver burden in all the three models. For instance, in Model 2, for
each unit increase in ADL, the number of hours of informal caregiving per week will increase by
4.468 units (β = 4.468, S.E. = 0.398, p < 0.001). Similarly, in Model 2, for each unit increase in
IADL, the number of hours of informal caregiving per week will increase by 2.755 units (β =
2.755, S.E. = 0.343, p < 0.001). These findings are consistent with earlier studies conducted by
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Edwards & Ruettinger (2002) and Cifu et al., (2006), who observed that higher caregiver burden
was associated with increased difficulties with ADL performance. Although prior studies have
not examined the relationship between IADL and caregiver burden, our study documents that
increase in the number of difficulties with IADLs was also associated with greater caregiver
burden.
The average hours per week of caregiving for care-recipients with PD was estimated to
be 27.51 (±35.04) hours as compared to 21.62 (±28.71) hours. Therefore, caregivers of carerecipients with PD spent substantially higher number of hours per week in caregiving compared
to those without PD. A study conducted by Parrish et al. (2003) found that informal caregivers
spent 96 hours/week in caregiving of care-recipients with PD. The average number of hours of
caregiving per week from the current study is considerably lower compared to the Parrish et al.
study. The study conducted by Parrish et al. (2003) was geographically limited as it was
conducted only in California and hence the findings from this study provides the estimate of
national average of hours per week of caregiving for care-recipients with PD. The high amount
of time spent on caregiving can lead to serious stress among caregivers and it has been in
documented in the existing literature that if more than 16 hours of caregiving per week is
provided, it leads to higher rates of nursing home placements of the care-recipients (Etters,
Goodall, & Harrison, 2008).
One of the unique contributions of this study is that it provided a nation-wide estimation
of costs associated with informal caregiving of for elderly individuals PD. Additionally, this
study compared costs associated with informal caregiving of care-recipients with and without
PD. It was found that the costs associated with informal caregiving of care-recipients with PD
were 1.27 times higher than care-recipients without PD. The high annual costs of informal care
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provided to the elderly individuals with PD have significant financial implications. With the
aging population of U.S. and the consequent expected increase in the number of individuals with
PD, efforts need to be devoted towards reducing informal caregiving burden.
Findings from this study also revealed that female caregivers are significantly more likely
to experience caregiver burden compared to male caregivers. This is consistent with the finding
from Edwards & Scheetz (2002) study where female caregivers reported double the burden as
compared to male caregivers. In general, the prevalence of PD is higher among men which in
turn influences the gender of caregivers, and it has been observed in existing studies (Edwards &
Scheetz 2002) as well as in this study that the number of female caregivers are higher among the
care-recipients of PD. Some of the reasons that we can speculate to explain the increased
caregiving burden among female caregivers may include the perception of not taking adequate
care of the care-recipients despite being the sole caregivers in most cases (Hooker et al. 2000).
Moreover, female caregivers sometimes believe that they are responsible for the condition of the
care-recipients (Hooker et al. 2000).
In this study, it was also indicated that use of paid caregiver is negatively associated with
caregiver burden. This finding is intuitive as the use of paid caregivers can lead to reduced
caregiving burden among informal caregivers. Existing studies did not account for paid
caregivers as one of the individual level variables.
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Strengths/Limitations
Some of the strengths of this study include nationally representative sample of elderly
care-recipients and their caregivers, ability to identify PD, and comprehensive list of variables
for both care-recipients and caregivers from survey data.
However, there are some limitations of this study. The study sample was small with only
32 caregivers of care-recipients with PD. This small sample size may affect the power of the
analyses. This data did not have information related to clinical factors such as the presence of
physical (e.g. diabetes) and/or mental conditions (e.g. depression, anxiety). Adjusting for
comorbid conditions may explain more variance in the caregiver burden. Moreover, duration and
severity of diseases was available. However, ADLs and IADLs may serve as global proxies for
severity of illness. Additionally, as this is a survey, presence of recall bias cannot be ruled out.
CONCLUSION
This is the first nationally representative study of caregiver burden among care-recipients
with PD. No significant differences were observed among in terms of caregiver burden among
caregivers of care-recipients with and without PD. However, findings from this study suggest
that caregivers of care-recipients with PD experience higher burden in terms of number of hours
of caregiving provided per week and also higher annual costs of informal caregiving. Number of
ADLs and IADLs explained most of the variance in caregiver burden. Thus findings from this
study suggest that several factors need to be taken into consideration while developing an
appropriate intervention to help caregivers deal with their caregiver burden.
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Table 1: Demographic characteristics of Caregivers and Care-recipients of Elderly Individuals
with and without PD
National Alliance for Caregiving, 2004, 2009, N= 1,671
PD
N = 32

Sig

No PD
N =1,639

Care-recipient characteristics
Age (years)

Mean ± S.D
81.29 ± 6.53

Mean ± S.D
80.69 ± 8.17

ADL score

3.14 ± 2.02

1.71 ± 1.96

IADL score

4.82 ± 2.01

4.41 ± 1.84

Age (years)

55.03 ± 14.19

52.05 ± 14.35

Other Independent Variables
Hours of caregiving per week

27.51 ± 35.04

21.62 ± 28.71

**

Caregiver characteristics

Care-recipient characteristics
Gender
Male

N
15

Col %
40.7

N
468

Col %
29.8

Female

16

55.8

1,147

68.7

Missing

1

3.5

24

1.6

Male

N
15

Col %
51.8

N
594

Col %
40.2

Female

17

48.2

1,045

59.8

Married

21

67.6

999

61.3

Others

11

32.4

640

38.7

11

35.3

381

19.2

21

64.7

1,258

80.8

17

48.1

728

46.0

Caregiver characteristics
Gender

Marital status

Living status of care-recipient
Lives in CG household
Lives elsewhere
Other Independent Variables
Paid Caregiver
Yes

No
15
51.9
911
Note: Based on 1,671 elderly care-recipients aged 65 or older.
CG: Caregiver; ADL: Activities of daily living; IADL: Instrumental activities of daily living
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54.0

*

Table 2: Caregiver Burden (Mean and Standard Deviations) by Caregiver and Other Characteristics
National Alliance for Caregiving, 2004, 2009, N= 1,671
CG Burden Scale †
Number of hours/week ‡
Informal CG cost ǂ
PD
No PD
Sig
PD
No PD
Sig
PD
No PD
N=32
N = 1,639
N=32
N = 1,639
N=32
N = 1,639
Characteristics
*
Sex of Caregiver
Female
1.95 ± 0.29
2.25 ± 0.04
20.56 ± 8.29
21.26 ± 0.98
Male
2.5 ± 0.25
2.02 ± 0.04
34.57 ± 9.91
18.2 ± 1.22
Marital Status of Caregiver
Married
2.31 ± 0.23
2.1 ± 0.04
26.19 ± 8.26
19.24 ± 0.96
Others
2.08 ± 0.39
2.24 ± 0.05
31.18 ± 11.44
21.28 ± 1.26
**
***
Care-recipient residency status
Lives in CG household
2.44 ± 0.33
2.63 ± 0.06
55.5 ± 12.27
47.46 ± 2.19
Lives elsewhere
2.13 ± 0.25
2.04 ± 0.03
12.72 ± 4.3
13.52 ± 0.67
***
***
ADLS
None
1.15 ± 0.15
1.77 ± 0.04
11.59 ± 5.42
9.85 ± 0.63
"1-2"
1.97 ± 0.42
2.06 ± 0.05
26.13 ± 13.71
16.35 ± 1.18
3, +
2.67 ± 0.18
2.75 ± 0.06
33.22 ± 9.18
37.57 ± 1.77
***
***
IADLS
Noneǂ
1.66
1.58 ± 0.19
2.00
3.78 ± 1.81
"1-2"
1.89 ± 0.51
1.61 ± 0.05
4.35 ± 0.79
7.75 ± 1.17
3, +
2.32 ± 0.23
2.28 ± 0.03
32.83 ± 7.68
23.07 ± 0.88
*
Presence of Paid Caregiver
Yes
2.2 ± 0.27
2.3 ± 0.05
25.11 ± 10.01
21.74 ± 1.24
No
2.27 ± 0.31
2.03 ± 0.04
30.32 ± 8.96
18.57 ± 0.94
Note: †Dependent variable was the computed Caregiver Burden
‡Dependent variable was the number of hours spent in caregiving per week
ǂ Dependent variable was the cost of informal caregiving in terms of 2013 US dollars
ADL: Activities of daily living; IADL: Instrumental activities of daily living
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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10,798 ± 4,358
18,158 ± 5,203

11,166 ± 517
9,560 ± 639

13,579 ± 4,340
16,381 ± 6,010

10,107 ± 503
11,174 ± 670

29,151 ± 6,446
6,684 ± 2,261

24,926 ± 1,151
7,105 ± 334

6,090 ± 2,844
13,723 ± 7,198
17,446 ± 4,826

5,170 ± 333
8,587 ± 620
19,729 ± 932

Sig

***

***

***
1,050
2,283 ± 413
17,241 ± 4,032

1,987 ± 953
4,069 ± 615
12,115 ± 463

13,188 ± 5,258
15,924 ± 4,708

11,420 ± 653
9,754 ± 493

*

Table 3: Parameter Estimates and Standard Errors from Ordinary Least Square Regressions on Caregiver Burden,
Number of Caregiving Hours and Log-transformed Costs Associated with Informal Care giving
National Alliance of Caregivers Survey (2004, 2009), N = 1,671
CG Burden Scale†
Characteristics
Intercept

Beta
0.985

S.E.
0.101

Beta
-13.005

S.E.
2.382

-0.153

0.146

-2.637

4.874

Age of Caregiver
Sex of Caregiver
Female

0.003

0.002

0.175

0.042

0.173

0.049

***

2.316

1.155

-0.103

0.051

*

-0.667

1.210

-0.031

0.071

23.413

2.267

ADLS

0.132

0.015

***

4.468

IADLS

0.139

0.015

***

Presence of Paid Caregiver
Yes

0.104

0.049

*

No
Number of hours spent in
caregiving/week

0.006

0.001

***

Parkinson's disease
Yes

Sig
***

Number of hours/week‡
Sig
***

Log-transformed
Informal CG Cost ǂ
Beta
6.598

S.E.
0.132

Sig
***

-0.133

0.227

***

0.006

0.002

**

*

0.170

0.057

**

-0.132

0.057

*

***

0.836

0.077

***

0.398

***

0.207

0.015

***

2.755

0.343

***

0.258

0.018

***

-0.965

1.200

-0.178

0.057

**

No

Male
Marital Status of Caregiver
Married
Others
Care-recipient residency status
Lives in Caregiver household
Lives elsewhere

-

-

-

Note: PD = 32, No PD = 1,639
†Dependent variable was the computed Caregiver Burden; This model was adjusted for presence or absence of PD,
Age of caregiver, Sex of caregiver, Marital status of caregiver, care-recipient‟s residency status, ADL, IADL,
presence or absence of paid caregiver, number of hours spent in caregiving per week
‡Dependent variable was the number of hours spent in caregiving per week; This model was adjusted for presence
or absence of PD, Age of caregiver, Sex of caregiver, Marital status of caregiver, care-recipient‟s residency status,
ADL, IADL, presence or absence of paid caregiver
ǂ Dependent variable was the log-transformed cost of informal caregiving; This model was adjusted for presence or
absence of PD, Age of caregiver, Sex of caregiver, marital status of caregiver, care-recipient‟s residency status,
ADL, IADL, presence or absence of paid caregiver
ADL: Activities of daily living; IADL: Instrumental activities of daily living
*** p < .001; **.001 ≤ p < .01; * .01 ≤ p < .05
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CHAPTER 4: Chronic Illness with Complexity: Diabetes Care among Elderly Medicare
Beneficiaries with Parkinson’s disease and Diabetes

INTRODUCTION
Chronic Illness with Complexity (CIC)
According to the National Quality Forum (NQF) and the Agency for Healthcare Research
and Quality (AHRQ) , CIC is defined as “two or more chronic conditions that have an adverse
effect on health status, function status, or quality of life of the patient and require complex
coordination of care” (http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifie). Due to
the presence of multiple morbidities, individuals with CIC are at a higher risk of limitations of
activities of daily living and disability (Weiss, 2007).
CIC is highly prevalent and has been increasing over time. In 2009, 145 million
(approximately half the United States population) Americans had one or more chronic
conditions, among which nearly half and more than a quarter of the individuals with chronic
conditions had multiple morbidities (chronic care chart book). According to the National Health
Interview Survey (NHIS) 2010, among elderly men 45.4% had 2-3 chronic illness and 17.1%
had four or more chronic illness, whereas among elderly women 47.4% had 2-3 chronic illness
and 14.5% had four or more chronic illness (NHIS 2010). Findings from 2009 MEPS revealed
that among elderly individuals 42.5% had 2-3 chronic illness while 24.6% had four or more
chronic illness (chronic care chart book).
CIC is associated with a wide array of negative health outcomes such as limitations of
functional status, decreased health-related quality of life, higher healthcare expenditures, greater
disability, adverse drug events, duplicative tests, contradictory medical advice, and lower
survival rates (Condelius, Edberg, Jakobsson, & Hallberg, 2008; Fortin, Bravo, Hudon, Vanasse,
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& Lapointe, 2005; Fortin, Soubhi, Hudon, Bayliss, & van, 2007; Gijsen et al., 2001; Marengoni,
von Strauss, Rizzuto, Winblad, & Fratiglioni, 2009; Schneider, O'Donnell, & Dean, 2009; van,
Buntinx, Metsemakers, Roos, & Knottnerus, 1998). For example, the average annual healthcare
expenditures among elderly individuals with two to three and four or more chronic illness was
estimated to be US$8,979 and US$15,553 (2006 US dollars) respectively (chronic care chart
book).
Chronic Illness with Complexity: Co-occurring Parkinson’s Diseases and Diabetes
T2DM and its complications (micro- and macro-vascular) are the leading causes for
morbidity and mortality in the United States (U.S.) (Shaw, Sicree, & Zimmet, 2010). Parkinson‟s
disease (PD) is a progressive neurodegenerative disease characterized by muscular tremor,
slowing of movement, partial facial paralysis, peculiarity of gait and posture (Muangpaisan et al.,
2011; Park & Stacy, 2009). According to the definition of CIC provided by AHRQ and NQF, cooccurring T2DM and PD can be considered as CIC their co-occurrence severely affects the
quality of life, and impairs health and functional status. Moreover, co-occurring T2DM and PD
require medical care from different specialties such as neurologists and endocrinologist, and
require care in different settings including home-based as well as facility-based care (Lapane,
Fernandez, & Friedman, 1999; Nocera, Horvat, & Ray, 2009). It has to be noted that the
prevalence of T2DM among elderly individuals with PD is comparable or slightly lower
compared to those without PD. A study conducted among elderly Medicare beneficiaries showed
that the prevalence rate of metabolic conditions did not differ significantly between individuals
with and without PD (Noyes, Liu, Li, Holloway, & Dick, 2006). Another study conducted among
a nationally representative sample of community-dwelling elderly individuals in the United
States found that the prevalence of T2DM was actually lower among individuals with PD
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compared to matched controls without PD (Bhattacharjee & Sambamoorthi, 2013). However, it
has been estimated that by 2030, the prevalence of both T2DM and PD will increase by
approximately two-folds due to the aging U.S. population (Dorsey et al. 2007) and will become a
major public health concern in the near future.
Need for the study
Chronic Illness with Complexity: Diabetes Process and Outcomes
Co-occurring PD and diabetes can pose significant challenges to diabetes management.
However, clinical guidelines for diabetes management for those with CIC are lacking. In general,
guidelines for clinical practice are developed based on the expert consensus and the scientific
evidence for a single disease state (Boyd et al., 2005). Standards of care and quality of care
improvement efforts are based on these guidelines for clinical practice. As for example, there are
separate guidelines for treating diabetes (such as the guidelines of the American Diabetes
Association) and PD (European Parkinson's Disease Standards of Care Consensus Statement).
Furthermore, studies on diabetes care among individuals with CIC have revealed mixed
findings. One study conducted among veterans with diabetes seeking care in seven different
Veterans Affairs (VA) facilities from July 2007 through June 2008 reported that veterans with
CIC were more likely to receive overall good quality for all three quality measures (glycemic,
blood pressure and low density lipoprotein-cholesterol control) combined (adjusted OR, 2.17;
95% CI, 1.96-2.39) (Woodard, Urech, Landrum, Wang, & Petersen, 2011). Whereas, another
study using the INTERMED classification system for case complexity found that greater
complexity among individuals with T2DM was associated with higher HbA1c values (Fischer et
al., 2000). Therefore, the aim of this study was to assess process and intermediate clinical
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outcomes of diabetes care among elderly individuals with CIC (T2DM and PD) compared to
those without CIC (T2DM without PD).
Conceptual Framework
The current study adapts elements from the Vector model of Complexity proposed by
Safford and colleagues (Safford, Allison, & Kiefe, 2007). This framework allows one to examine
CIC with different factors such as socio-economic (e.g. insurance status), cultural (e.g.
race/ethnicity), biological/genetic (e.g. gender), external environmental (e.g. region), and
healthcare use (e.g. co-medication use) contributing to complexity. Patient complexity can occur
from any axis, but primary focus is often given on the underlying biological axis by physicians.
Each of the axes in this model is interconnected with the other as depicted by the web, and even
in case of not being connected by adjacent web, the axes are still connected with each other.
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Figure 1: Conceptual Framework: Vector model of Complexity
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Outcomes

METHODS
Study Design
A retrospective cohort design (2007-2008, 2008-2009, 2009-2010, 2010-2011) using
matched case-control approach with observational data was used for the purposes of this study.
For each elderly individual with T2DM, the observation period consisted of 24 months with 12month baseline period and 12-month follow-up period. For example, if T2DM and PD cases
were identified in 2007, 2007 served as the baseline year, and 2008 served as the follow-up
period. Process of care and intermediate clinical outcomes were measured during the follow-up
year (i.e. 2008).
Data Source
The Humana Medicare Advantage Part D database (MAPD) from January 2007 through
December 31, 2011 was used for this study. The Humana claims database consists of more than
12 million current and previous enrollees among which 1.9 million enrollees are from MAPD
plans. This study used medical, prescription, laboratory claims and person enrollment summary
files. The medical claims contained information related to the type of plan, treatment date, type
of admission (trauma, elective, emergency etc.), inpatient length of stay, diagnosis and
procedural codes, and total Medicare allowable charges associated with each claim. Prescription
claims included information on prescription fill date, medication dispensed, quantity of
medication dispensed, net amount paid by Humana and out-of-pocket costs for enrollees.. The
laboratory Claims contained information on lab test identifying codes, lab results and abnormal
value indicator. However, laboratory results are available only for approximately 30% of the
laboratory claims. The patient enrollment summary file included information on the MAPD
enrollees age, sex, race/ethnicity, and enrollment dates.
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Study Population
The study population consisted of elderly Medicare beneficiaries (≥65 years) with
T2DM. Elderly Medicare beneficiaries with T2DM were identified by the presence of a
minimum of one inpatient or two outpatient visits (at least of 30 days apart) with a primary or
secondary diagnosis of T2DM [International Classification of Diseases 9th Modification (ICD-9CM) code: 250.x0 or 250.x2] (Wang, Wei, Miao, Xie, & Baser, 2013; Xie et al., 2013).
Inclusion Criteria:
Other inclusion criteria were: (i) continuous enrollment of 24 months (at baseline and
follow-up year); and (ii) receipt of at least one oral antidiabetic drug (OAD) or insulin during the
baseline year.
Dependent Variables
Process of Care
The three processes of care measures used in this study included: (i) HbA1c testing; (ii)
lipids testing; and (iii) nephropathy screening. These measures were considered to meet the
American Diabetes Association (ADA) guidelines if: (1) HbA1c testing was conducted at least
two times a year with a gap of at least three months; (2) lipid testing was conducted at least once
a year; and (3) nephropathy screening was conducted at least once a year. A detailed description
of the CPT and HCPCS codes are provided in Appendix I.
Intermediate Clinical Outcomes
Glycemic control
HbA1c > 9% represents poor glycemic control and is considered to be a poor
performance marker among all elderly individuals with CIC (Meduru 2007). One study has used
HbA1c < 7% is representative of optimal glycemic control (Meduru et al., 2007). However,
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among elderly individuals HbA1C < 8% is often considered as acceptable glycemic control
(HEDIS. Technical Specifications). Therefore, glycemic control outcomes were classified into
three groups based on HbA1c values as follows: (i) < 8%; (ii) ≥ 8%. This outcome was measured
only among those with HbA1c values.
Lipid Control
Lipid control outcomes were based on Low Density Lipoprotein Cholesterol (LDL-C),
High Density Lipoprotein Cholesterol (HDL-C), triglycerides, and total cholesterol. These lipid
control outcomes were categorized based on the American Diabetes Association guidelines.
LDL-C was categorized as follows: (i) <100 mg/dl; (ii) ≥ 100 mg/dl and (iii) no LDL-C value.
HDL-C was categorized into two groups for both men and women as follows: (i) ≤ 40 mg/dl for
men; (ii) > 40 mg/dl for men; (iii) ≤ 50 mg/dl for women; and (iv) > 50 mg/dl for women.
Triglycerides were classified into two groups as follows: (i) <150 mg/dl; (ii) ≥ 150 mg/dl, and
(iii) no triglyceride values. Total cholesterol was divided into groups as follows: (i) < 200 mg/dl;
(ii) ≥ 200 mg/dl (ADA guidelines). Again these were restricted to individuals with available
laboratory values.
Key Independent variable: Presence of PD
The key independent variable for all analyses was presence or absence of PD.
Identification of PD was achieved by using ICD-9-CM code of 332.xx during the baseline year.
The diagnosis of PD was ascertained by the presence of at least one inpatient or two outpatient
visits (30 days apart) with a primary or secondary diagnosis of PD (ICD-9-CM code: 332.xx).
PD cases were matched with those without PD using propensity scores generated by conducting
a logistic regression on presence/absence of PD which adjusted for gender, age, and diabetes
complications severity index (DCSI). One case was matched to three controls based on 8 to 1
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GREEDY matching technique using propensity score. For 8 to 1 GREEDY matching, the cases
and control with same propensity score till the 8th digit are matched, and if they do not match on
8 digits, then it goes to 7-digit matching and so on. The GREEDY matching technique employs a
sample without replacement algorithm and if there are more than one matches, then selection of
control becomes random. Additionally, it was ensured that controls should be from the same
calendar year as the cases (i.e. if individuals were identified with PD in 2008, all controls will be
from 2008).
Independent variables
Patient Complexities
According to the American Geriatric Society (AGS) guidelines, individuals having
specific conditions such as cognitive impairment, depression, fall and falls risk, polypharmacy,
and urinary incontinence should be provided individualized treatment (Inouye et al. 2007). These
characteristics were measured during the baseline period. Elderly Medicare beneficiaries were
considered to have cognitive impairment due to physical illnesses if they had a diagnosis of
Huntington‟s disease, delirium, dementia, amnestic and other cognitive disorders; whereas if
they have a diagnosis of bipolar disorder, schizophrenia and other psychotic disorders, they were
considered to have cognitive impairment due to mental illnesses. Elderly Medicare beneficiaries
were considered to have any cognitive impairment if they had either mental and/or physical
cognitive impairment. To identify accidental falls, E-codes E880 through E888 were used
whereas V-code V15.88 was used as a proxy measure for falls risk (Mehta et al. 2010; Tinetti et
al. 2006). Number of therapeutic classes of prescribed medications was used to define
polypharmacy, and was categorized into quintiles: (i) 0-0, (ii) 1-1, (iii) 2-3, (iv) 4-5, and (v) 6-31.
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Dominant Comorbid Conditions
Using the framework of Kerr and Piette, cancer, end stage renal disease, and end stage
liver disease were included as a dominant comorbid condition in this study (Piette et al. 2006).
Other independent Variables
Other independent variables consisted of socio-economic, cultural, and
environmental/ecological variables. Socio-economic variables consisted of (i) Medicare
prescription drug coverage gap; and (ii) insurance status (Private Fee-for-service, Health
Maintenance Organization, and other insurance). Environmental factors consisted of (i) region
(South, Mid-West, and Other regions). The cultural factor was defined by race/ethnicity (Whites,
African- Americans, Hispanics, and Others).
Statistical Analyses
Unadjusted differences among elderly individuals with and without Parkinson‟s disease
were determined using chi-square tests. Conditional Logistic regression analyses and conditional
multinomial logistic regression analyses were conducted for binary dependent variables and
dependent variables with more than two levels respectively. As 30% of the study cohort did not
have laboratory values, sample selection models were also conducted to test selection bias
among individuals with and without laboratory values. This was accomplished using “Heckprob”
selectivity corrected regression. These models consisted of a selection equation in which the
presence or absence of laboratory values were modeled. In the outcome equation, the
intermediate outcomes were modeled. For example, for HbA1c control, a logistic regression
analysis on the presence or absence of HbA1c values was conducted. In the outcome equation,
glycemic control (<8% and > 8%) was modeled. The Wald test of independence showed that the
chi-square probability value was 0.7968 indicating that there is no influence of unobserved
variables on glycemic control outcome in this dataset. Similar findings were observed with the
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lipid outcomes. Therefore, we report results from analyses among elderly individuals with
available HbA1C values and lipid values.
Propensity Score Matching
Before propensity score matching, there were 2,727 individuals with PD and diabetes
(cases), and 249,763 individuals with diabetes only (controls). After propensity score matching
and removing pairs with inexact matches, there were 2,703 individuals with PD and diabetes and
8,109 individuals with diabetes only (1:3 case to control matching). The cohort development is
depicted in Figure 1. Age (in years) and Diabetes Complications Severity Index (DCSI) total
were continuous variables and the group differences in these two variables were ascertained by ttests. For gender the group differences were ascertained by using chi-square. The number of
individuals with Parkinson‟s disease (PD) and before and after matching in each year are
different because of the fact that we found that 1,282 individuals without PD in previous years
were diagnosed with PD in the following year, and as these individuals were included in the
control dataset for a particular year, they were deleted from the control dataset so that we do not
have overlap between case and control group during matching. For each year, the individuals
with PD in the matched sample were unique cases.
The two groups were matched on age, gender and DCSI scores. The c-statistics of the
logistic regression to calculate propensity score for each year were found to be satisfactory
(around 0.70). From Table 1, it can be noted that, before propensity score matching, the two
groups differed significantly from each other in terms of age, DCSI total and gender distribution.
Before matching, among individuals with T2DM and PD, the total mean DCSI score was
significantly higher compared to those with only diabetes. In terms of age, individuals with PD
and diabetes had a significantly higher mean age as compared to those with diabetes only prior to
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propensity score matching. The PD and diabetes group had significantly higher number of males
as compared to the group with diabetes only before matching. The propensity score matched
sample was found to be well balanced in terms of the variables that were used to match the two
groups. After matching there were no significant differences between the two groups in terms of
age, DCSI and gender. From Table 2, it can be noted that when the 4 panels (2007-2008, 20082009, 2009-2010, and 2010-2011) were stacked, there were no statistically significant group
differences in terms of age, gender and DCSI.
RESULTS
Description of Study Sample by PD status
Table 3 exhibits baseline characteristics of T2DM elderly individuals with and without
PD. There was significantly higher proportion of African-Americans (14.4%) among individuals
with only diabetes. Overall, both the groups (individuals with T2DM and PD and with diabetes
only) had higher proportions of whites (75.7% and 74.3% respectively). In terms of region and
plan types, there were higher proportion of individuals in the South region (around 75%) and
Health Maintenance Organizations in both the groups (around 48%). There was significantly
higher proportion of individuals who did not reach donut hole (56.6%) among individuals with
only diabetes, whereas the group with PD and diabetes had higher proportions of individuals
entering (44.9%) and having entry and exit information regarding donut hole (17.7%).
Individuals with PD and diabetes had significantly greater proportion of polypharmacy users in
the higher quintiles (4-5, and 6-31). With respect to the conditions specific to elderly individuals,
individuals with PD and diabetes had significantly higher proportion of urinary incontinence
(10.4%), major depressive disorders (26.7%), cognitive impairment (33.4%), and falls and falls
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risk (9.9%). Individuals with PD and diabetes had a higher proportion of baseline emergency
room (55.5%) and baseline home health visit (60.9%).
Description of Process of Care and Intermediate Clinical Outcomes
Table 4 summarizes the findings in terms of process of care measures and intermediate
clinical outcomes. Overall, 66.84% had ADA recommended HbA1c testing. A lower percentage
of individuals with T2DM and PD received HbA1c testing (63.7%) compared to those with
T2DM and no PD (67.9%, P-value <0.001).
An overwhelming majority of individuals with T2DM received lipid testing (84.65%). A
lower percentage of elderly individuals with T2DM and PD (80.4%) received lipid testing
compared to those with T2DM and no PD (86.1%, p-value < 0.001). No statistically significant
differences were observed in the two groups in terms of nephropathy screening.
Among elderly individuals with available HbA1C values, an overwhelming majority had
HbA1C value of < 8% in both individuals with T2DM and PD (86%) and T2DM and no PD
(83.8%). Elderly individuals with T2DM and PD had statistically significantly better
intermediate clinical outcomes compared to those with T2DM and no PD in terms of LDL-C<
100mg/dl (75.5% vs. 69.8%), triglycerides < 150mg/dl (63.8% vs. 58.6%), total cholesterol <
200mg/dl (87.2% vs. 83%) and HDL-C ≥ 50mg/dl (39.8% vs. 35.7%).
Multivariable Conditional Logistic Regression on Process of Care
Table 5 shows the results of conditional logistic regression analyses conducted with
HbA1c testing as the dependent variable adjusting for the matched pair design. After controlling
for Parkinson‟s disease, race/ethnicity, region, plan-type, donut hole, polypharmacy, urinary
incontinence, depression, falls and fall risk, cognitive impairment due to physical conditions,
cognitive impairment due to mental conditions, dominant conditions, baseline emergency room
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visits, baseline home health visits and adjusting for the matched pair design, it was observed that
individuals with PD and diabetes were 12% (AOR: 0.88, 95%CI: 0.79-0.97) and 18% (AOR:
0.82, 95%CI: 0.72-0.94) less likely to meet the annual ADA recommended HbA1c and lipid
testing respectively compared to individuals with diabetes and without PD. However, there were
no statistically significant difference between individuals with and without PD in terms of
nephropathy testing (AOR: 0.99, 95%CI: 0.88-1.10).
Table 6 depicts the results from conditional multinomial logistic regression with
glycemic control as the dependent variable. After adjusting for Parkinson‟s disease,
race/ethnicity, region, plan-type, donut hole, polypharmacy, urinary incontinence, depression,
falls and fall risk, cognitive impairment due to physical conditions, cognitive impairment due to
mental conditions, dominant conditions, baseline emergency room visits, baseline home health
visits and matched pair design, it was observed that individuals with T2DM and PD were 34%
(AOR: 1.34, 95%CI: 1.10-1.63) more likely to have better glycemic control (HbA1c < 8%)
compared to those with T2DM and without PD. Individuals with T2DM and PD were higher
likely to have better outcomes in terms of LDL-C (<100mg/dl) (AOR: 1.29, 95%CI: 1.06-1.59),
triglyceride (<150mg/dl) (AOR: 1.31, 95%CI: 1.06-1.62), total cholesterol (<200mg/dl) (AOR:
1.46, 95%CI: 1.08-1.97) and HDL-C (≥ 50mg/dl) (AOR: 1.20, 95%CI: 1.04-1.39).
DISCUSSION
This study examined the association between CIC and process and intermediate outcomes
of diabetes care among elderly individuals with T2DM. CIC was defined as the co-occurrence of
T2DM and PD. Results from this study indicated that among individuals with T2DM, those with
PD did not receive the ADA recommended HbA1c and lipid testing compared to those without
PD. These findings suggest that, CIC is a barrier to achieving clinically recommended process of
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care measures. Some of the reasons which may lead to not achieving the ADA recommended
HbA1c and lipid testing can be that elderly Medicare beneficiaries may not be aware of the
benefits of meeting these goals, or there can be a gap in patient-provider communication, or the
elderly Medicare beneficiaries may not be visiting their physicians on a regular basis (Delaronde,
2005). Some ways in which these barriers can be overcome include educating patients and
underscoring and helping in attending group consultations by healthcare providers (Van Dam et
al. 2003). Moreover, for managed care settings, telephone follow-up and/or reminders have been
seen to be effective (Rubin, Dietrich & Hawk, 1998). Another plausible reason for not achieving
ADA recommended goals may be due to competing demands of elderly Medicare beneficiaries
with T2DM and PD. It is possible that the severity of PD may be high in this group of patients
and providers might be focusing on treating PD than T2DM. However, as the measure of
severity of PD in claims database is not available, this remains one of the unmeasured factors
that can be influencing the study findings.
A noteworthy finding from our study is the relationship between CIC and intermediate
clinical outcomes of diabetes care. For glycemic and lipid outcomes, elderly individuals with
T2DM and PD were more likely to achieve control compared to those with T2DM and no PD. A
plausible explanation for better outcomes among those with T2DM and PD could be due to
pathophysiological conditions of the two diseases. For example, it has been suggested that
insulin resistance and insulin deficiency, which are the cardinal characteristics of T2DM, can
lead to neurodegeneration (Peila, Rodriguez, White, & Launer, 2004; Rönnemaa et al., 2008;
Rönnemaa et al., 2009). It is possible that given the risk of neurodegeneration due to T2DM, the
providers may be aggressively treating individuals with T2DM and PD for better glycemic and
lipid outcomes in order to prevent further neurodegeneration. The findings from this study are
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consistent with a study conducted among elderly veterans, which showed that veterans with CIC
were more likely to receive overall good outcomes for all 3quality measures (glycemic, blood
pressure and low density lipoprotein-cholesterol) combined (adjusted OR, 2.17; 95% CI, 1.962.39) (Woodard, Urech, Landrum, Wang, & Petersen, 2011). One of the similarities between VA
and the Medicare Advantage plans is that they follow the Integrated Delivery System (IDS)
model. In the IDS model, the primary physician serves as the gate-keeper and maintains proper
referral systems. The coordination of care among different types of specialists (Endocrinologists,
Neurologists etc.) is ensured in the IDS models which in turn could lead to better management of
individuals with CIC. The consistent finding of better glycemic and lipid outcomes among
individuals with CIC in these two studies can be partially attributed to the better care
coordination in these systems.
However, the findings from this study is inconsistent with the findings from the study
using the INTERMED classification system for case complexity which found that among
individuals with T2DM, greater complexity was associated with higher HbA1c values (Fischer et
al., 2000). The INTERMED classification system utilized different factors such as biological,
psychosocial and health care related aspects of T2DM to classify patient complexity and had
only 61 patients in the study. The results presented were in the preliminary forms and it required
further validation. Hence, it is possible that due to different classification system used to
determine patient complexity, greater risk of poor diabetes control among individuals with
higher complexity was observed.
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Strengths and Limitations
Strengths of this study include the use of large sample size, nationwide sample of
commercially insured elderly individuals, exhaustive list of variables, availability of laboratory
values and use of a robust study design.
As with other studies, this study also has limitations. Findings from this study cannot be
generalizable to other populations or settings (e.g. fee-for-service Medicare beneficiaries).
Laboratory values are available for only one-third of the population. Unmeasured confounders
such lifestyle risk factors (e.g. body mass index and smoking status), physician specialty,
duration and severity of PD could influence the study outcomes.
CONCLUSION
To the best of author‟s knowledge, this is the first study to examine the effect or
influence of the presence of a chronic illness with complexity such as PD on the process and
outcomes of diabetes care. Individuals with PD and diabetes were less likely to achieve ADA
recommended annual HbA1c and lipid testing goals compared to those with diabetes but without
PD. Future research needs to explore the reasons for lower rates of HbA1C and lipid testing
among elderly individuals with T2DM and PD. However, among individuals with CIC, the
intermediate glycemic and lipid outcomes were better compared to those without CIC. These
findings suggest that the integrated delivery system of Medicare Advantage plans may be
beneficial to elderly with CIC.
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Table 1: Distribution of Matching Variables before and after Propensity Score Matching
Humana Medicare Advantage Part-D Database (2007-2011)
Before Matching

After Matching

2007
PD

No PD

PD

No PD

N= 775

N= 101,306

Sig

N= 775

N= 2,325

Age (Mean ± SD)

74.57 (± 4.96)

DCSI Total (Mean ± SD)

3.42 (± 2.38)

72.56 (± 5.02)

***

74.57 (± 4.96)

74.56 (± 4.95)

2.22 (± 2.11)

***

3.42 (± 2.38)

3.42 (± 2.38)

Sig

***

Gender
Male (N, %)

461 (59.48%)

47,844 (47.23%)

461 (59.48%)

1,385 (59.57%)

Female (N, %)

314 (40.52%)

53,462 (52.77%)

314 (40.52%)

940 (40.43%)

PD

No PD

2008
PD

No PD

N= 949

N= 120,136

Sig

N= 571

N= 1,713

Age (Mean ± SD)

75.16 (± 5.18)

72.80 (± 5.19)

***

74.95 (± 5.32)

74.94 (± 5.32)

DCSI Total (Mean ± SD)

3.46 (± 2.34)

2.31 (± 2.15)

***

3.42 (± 2.33)

3.42 (± 2.34)

Male (N, %)

535 (56.38%)

56,985 (47.43%)

307 (53.77%)

919 (53.65%)

Female (N, %)

414 (43.62%)

63,151 (52.57%)

264 (46.23%)

794 (46.35%)

PD

No PD

Sig

***

Gender

2009
PD

No PD

N= 1,208

N= 144,290

Sig

N= 667

N= 2,001

Age (Mean ± SD)

75.24 (± 5.48)

73.00 (± 5.37)

***

74.54 (± 5.61)

74.59 (± 5.60)

DCSI Total (Mean ± SD)

3.59 (± 2.38)

2.44 (± 2.19)

***

3.57 (± 2.47)

3.54 (± 2.41)

Male (N, %)

710 (58.77%)

68,650 (47.58%)

382 (57.27%)

1,153 (57.62%)

Female (N, %)

498 (41.23%)

75,640 (52.42%)

285 (42.73%)

848 (42.38%)

PD

No PD

Sig

***

Gender

2010
PD

No PD

N= 1,384

N= 170,941

Sig

N= 714

N= 2,142

Age (Mean ± SD)

75.43 (± 5.63)

73.20 (± 5.48)

***

74.77 (± 5.88)

74.79 (± 5.87)

DCSI Total (Mean ± SD)

3.66 (± 2.43)

2.49 (± 2.21)

***

3.65 (± 2.44)

3.64 (± 2.42)

Sig

***

Gender
Male (N, %)

815 (58.89%)

80,924 (47.34%)

416 (58.26%)

1,250 (58.36%)

Female (N, %)

569 (41.11%)

90,017 (52.66%)

298 (41.74%)

892 (41.64%)

Note: This table presents the matching variable distribution before and after propensity score matching by individual
year.
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
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Table 2: Distribution of matching variables after Propensity Score Matching
Humana Medicare Advantage Part-D Database (2007-2011 stacked)
PD
No PD
N= 2,703
N= 8,109
p-value
Sig
74.67 (± 5.44)
74.67 (± 5.44)
1.0000
Age (Mean ± SD)
3.46 (± 2.34)
3.46 (± 2.34)
1.0000
DCSI Total (Mean ± SD)
1.0000
Gender
1,554 (57.5%)
4,662 (57.5%)
Male (N, %)
3,447 (42.5%)
Female (N, %) 1,149 (42.5%)
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries
(2,703cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes
Mellitus) during the period of January 2007 to December 2011.
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
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Table 3: Baseline characteristics of Elderly Medicare Beneficiaries after
matching
Humana Medicare Advantage Part-D Database (2007-2011)

PD

Col %

No PD

Col %

Race/Ethnicity
White
African American
Other
Unknown
Region
South
Midwest
Other Region
Plan Type
HMO
PFFS
Others
Donut Hole
No DH
Beg DH
Beg/End DH
DCSI Quintile
0–0
1–1
2–2
3–4
5 - 13
Polypharmacy quintile
0–0
1–1
2–3
4–5
6 - 31
Urinary Incontinence
Yes
No
Major Depressive Disorder
Yes
No
Cognitive Impairment
Yes
No
Dominant Conditions
Yes
No
Falls and falls risk
Yes
No

268
2435

9.9
90.1

354
7755

4.4
95.6

Baseline ER visit
Yes
No

1500
1203

55.5
44.5

3172
4937

39.1
60.9

2,047
293
169
194

75.7
10.8
6.3
7.2

6,025
1,168
446
470

74.3
14.4
5.5
5.8

1,806
604
293

66.8
22.3
10.8

5,223
1,778
1,108

64.4
21.9
13.7

1,315
918
470

48.6
34.0
17.4

3,648
2,536
1,925

45.0
31.3
23.7

1,012
1,213
478

37.4
44.9
17.7

4,590
2,937
582

56.6
36.2
7.2

619
421
619
504
540

22.9
15.6
22.9
18.6
20.0

1,857
1,263
1,857
1,512
1,620

22.9
15.6
22.9
18.6
20.0

357
454
539
620
733

13.2
16.8
19.9
22.9
27.1

1,644
1,749
1,818
1,570
1,328

20.3
21.6
22.4
19.4
16.4

280
2,423

10.4
89.6

353
7,756

4.4
95.6

722
1,981

26.7
73.3

963
7,146

11.9
88.1

904
1,799

33.4
66.6

686
7,423

8.5
91.5

340
2363

12.6
87.4

989
7120

Sig
***

***

***

***

***

***

***

***

12.2
87.8
***

***

Contd.
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Table 3: Baseline characteristics of Elderly Medicare Beneficiaries after
matching
Humana Medicare Advantage Part-D Database (2007-2011)

PD
Col %
No PD
Col %
Sig
***
Baseline HH visit
Yes
1647
60.9
3736
46.1
No
1056
39.1
4373
53.9
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries
(2,703cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes
Mellitus) during the period of January 2007 to December 2011.
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; ER: Emergency Room; HH: Home Health; HMO: Health
Maintenance Organization; PFFS: Private Fee for Service; Sig: Significance; LDL: Low Density Lipoprotein; HDL:
High Density Lipoprotein; Trigly: Triglyceride; yr: Year; chol: Cholesterol.
Asterisks represent significant group differences in HbA1c testing according to American Diabetes Association
(ADA) guidelines using conditional logistic regression adjusting for the matched pair design:
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
†Dominant conditions consisted of cancers, end stage renal disease, end stage liver disease, and amputations
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Table 4: Description of Process of Care and Intermediate Clinical Outcomes
Humana Medicare Advantage Part D database (2007-2011)
PD
Col %
No PD
Col %
N = 2,703
N = 8,109
HbA1c Testing
Yes
1,722
63.7
5,505
67.90
No
981
36.3
2,604
32.10
Lipid Testing
Yes
2,174
80.4
6,978
86.10
No
529
19.6
1,131
13.90
Nephropathy Screening
Yes
2,027
75.0
6,015
74.20
No
676
25.0
2,094
25.80
Intermediate Clinical Outcomes among those with Available Laboratory Values
PD
No PD
HbA1c groups
N= 1,247
N = 3,736
HbA1c >= 8%
174
14.0
604
16.2
HbA1c < 8%
1,073
86.0
3,132
83.8
LDL-C groups
N = 559
N = 1938
>= 100 mg/Dl
137
25.0
586
30.2
0<= LDL < 100
422
75.0
1,352
69.8
Triglyceride groups
N = 558
N = 1977
trigly>= 150 mg/DL
202
36.0
819
41.4
0<= trigly< 15mg/DL
356
64.0
1,158
58.6
Total Cholesterol groups
N = 561
N = 1982
Tot Chol >= 200mg/DL
72
13.0
336
17.0
Tot Chol < 200mg/DL
489
87.0
1,646
83.0
HDL-C groups
N = 1157
N = 3676
HDL < 50 mg/Dl
696
60.0
2,364
64.3
HDL >= 50 mg/Dl
461
40.0
1,312
35.7

Sig
***

***

**

*

*

*

Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus)
during the period of January 2007 to December 2011 (except the bottom panel).
PD: Parkinson‟s disease; Sig: Significance; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein;
Trigly: Triglyceride; yr: Year; chol: Cholesterol.
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
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Table 5: Adjusted Odds Ratios and 95% Confidence Intervals from
Conditional Logistic Regressions Process of Care Measures as per ADA
Guidelines
Humana Medicare Advantage Part D (2007-2011)
AOR
95% CI
Sig
HbA1c Testing
PD
0.88 [0.79,0.97]
*
No PD (Reference Group)
Lipid Testing
PD
0.82 [0.72,0.94] **
No PD (Reference Group)
Nephropathy Testing
PD
0.99 [0.88,1.10]
No PD (Reference Group)
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus)
during the period of January 2007 to December 2011.
Model adjusted for: Race/Ethnicity, Region, Insurance Plan Type, Donut Hole, Polypharmacy, Urinary
Incontinence, Cognitive Impairment due to physical conditions, Cognitive Impairment due to mental conditions,
Falls and Falls Risk, Major Depressive Disorder, Baseline Emergency Room visit, Baseline Home Health visit,
Dominant conditions (cancers, end stage renal disease, end stage liver disease, and amputations).
PD: Parkinson‟s disease AOR: Adjusted Odds Ratio; CI: Confidence Interval; Sig: Significance.
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
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Table 6: Adjusted Odds Ratios and 95% Confidence Intervals from
Multinomial Conditional Logistic Regressions on Intermediate
Outcomes
Humana Medicare Advantage Part D (2007-2011)
AOR
95% CI
Sig
HbA1c <8% vs ≥ 8%
PD
1.34
[1.10,1.63]
**
No PD (Reference Group)
LDL-C <100 mg/dL vs ≥ 100 mg/dL
PD
1.29
[1.06,1.59]
*
No PD (Reference Group)
Triglyceride <150mg/dL vs ≥ 150 mg/dl
PD
1.31
[1.06,1.62]
*
No PD (Reference Group)
HDL-C ≥ 50 mg/dL vs ≥ 50 mg/dL
PD
1.20
[1.04,1.39]
*
No PD (Reference Group)
Total Cholesterol < 200 mg/dL vs. ≥ 200
mg/dl
PD
1.46
[1.08,1.97]
*
No PD (Reference Group)
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus)
during the period of January 2007 to December 2011.
Model adjusted for: Race/Ethnicity, Region, Insurance Plan Type, Donut Hole, Polypharmacy, Urinary
Incontinence, Cognitive Impairment due to physical conditions, Cognitive Impairment due to mental conditions,
Falls and Falls Risk, Major Depressive Disorder, Baseline Emergency Room visit, Baseline Home Health visit,
Dominant conditions (cancers, end stage renal disease, end stage liver disease, and amputations).
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; CI: Confidence Interval; Sig: Significance; LDL-C: Low
Density Lipoprotein Cholesterol; HDL-C: High Density Lipoprotein Cholesterol.
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05
Reference groups: ≥8% HbA1c; LDL-C ≥ 100mg/dL; Triglyceride ≥ 150mg/dL; LDL-C ≥ 50mg/dL; Total
Cholesterol ≥ 200mg/dL.
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Figure 1: Cohort development

Before Matching
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No PD = 2,001
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Pooled (2007-2010)
PD = 2,727
No PD = 8,181
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inexact pair
matching

Final cohort
PD = 2,703
No PD = 8,109
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Appendix I

HbA1c testing
Individuals with HbA1c testing at least two times a year (with a gap of at least one
month) will be considered as meeting standard of care for diabetes management. HbA1c
testing will be identified by the following Current Procedural Terminology (CPT) codes.
a. CPT codes: 83036, 83037 (Source : HEDIS, 2012)
b. CPT Category II : 3044F, 3045F, 3046F, 3047F (Source : HEDIS, 2012)

Lipid testing
Individuals who were tested at least once a year will be considered as meeting standard of
care for diabetes management. Lipid testing will be identified by the following Current
Procedural Terminology (CPT) codes.
a. CPT codes: 80061, 83700, 83701, 83704, 83721, 83715, 83716, 83718, 82465,
and 84478 (Source: Morrato et al. 2008; HEDIS, 2012)
b. CPT Category II: 3048F, 3049F, 3050F

Nephropathy screening
Individuals who were screened at least once a year for urine albumin and serum
creatinine will be considered as meeting standard of care for diabetes management.
Nephropathy screening will be identified using the following Current Procedural
Terminology (CPT) codes.
a. CPT codes: 81000, 81001, 81002, 81003, 36800, 36810, 36815, 50300, 50340,
50360, 50365, 50370, 50380, 90920, 90921, 90924, 90925, 90935, 90937, 90945,
90947, 90989, 90993, 90997, and 90999 82579 for serum creatinine lab (Mainous
et al. 2001); 82042, 82043, 82044, 84156 (Source: HEDIS, 2012)
b. CPT Category II: 3060F, 3061F (Source: HEDIS, 2012)
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CHAPTER 5

DISCUSSION & CONCLUSIONS
SUMMARY OF FINDINGS

The purpose of this dissertation was to use observational data from real-world settings to
provide a comprehensive view of the burden of illness among elderly individuals with PD. We
answered three research questions pertaining to the economic impact of both formal and informal
caregiving burden and the impact of chronic illness with complexity on process and intermediate
clinical outcomes among elderly individuals with PD. Economic impact of formal caregiving
burden was assessed by estimating the home healthcare use and expenditures among elderly
Medicare beneficiaries with PD compared to those without PD. Focusing on a Medicare
population to assess the impact of economic burden of formal caregiving is appropriate as
Medicare provides near universal coverage for elderly individuals in the U.S. Economic burden
of the informal caregiving was estimated by multiplying number of caregiving hours per week by
the median wage ($10.10/hour) of a household aide. Informal caregiver burden was also
measured based on three questions on physical strain, emotional stress and financial hardship on
the informal caregivers. Chronic illness with complexity (CIC) was defined as the co-occurrence
of PD and type 2 diabetes mellitus (T2DM). It is important to assess the process and intermediate
outcomes among elderly individuals with CIC as it has been estimated that by 2030, the
prevalence of both T2DM and PD will increase by approximately two-folds due to the aging
U.S. population (Dorsey et al. 2007) and will become a major public health concern in the near
future. Due to the unavailability of a single database that can answer all these research questions,
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we used a triangulation approach by using data from different sources to answer the research
questions of this dissertation.
The first research question of this dissertation was to estimate the excess home healthcare
use and expenditures among elderly Medicare beneficiaries with PD compared to those without
PD using the national Medicare 5% claims database (2006-2007). In this aim, we also estimated
the extent to which the individual-level factors such as predisposing, enabling, need, personal
health behaviors, and external environmental factors contributed to the differences in home
healthcare use and expenditures between elderly Medicare beneficiaries with and without PD.
Elderly Medicare beneficiaries with PD had 13.28 percentage points (PD: No PD:: 22.50% vs.
9.22%) higher home healthcare use compared to those without PD. Multivariate analysis also
revealed similar findings with elderly Medicare beneficiaries with PD having greater than two
times more likelihood to have home healthcare use compared to those without PD. It was
estimated that the average home healthcare expenditures among elderly Medicare beneficiaries
(who used home healthcare service) with PD was 1.34 times higher compared to those without
PD ($6,792 vs. $5,060). Multivariate Ordinary Least Square (OLS) regression analysis showed
consistent findings. These findings are consistent with previous studies which showed that home
healthcare use and expenditures among individuals with PD are significantly higher among
individuals with PD ((Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al.,
2003; Rubenstein, Chrischilles, & Voelker, 1997)). The unique contribution of this study was to
estimate the extent to which individual-level factors explained the home healthcare use and
expenditures among elderly Medicare beneficiaries. Approximately 27% of the differences in
home healthcare use between elderly Medicare beneficiaries with and without PD were
explained by the predisposing, need, personal health choice and external environmental factors.
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However, only 11% of the total home healthcare expenditure differences between elderly
Medicare beneficiaries with and without PD were explained by the individual-level factors used
in this study. Personal health behaviors such as baseline resource use and need factors such as
mental and physical health conditions explained the highest proportion of the home healthcare
use and expenditure differences.
The second question of this dissertation focused on assessing the informal caregiver
burden among caregivers of elderly care-recipients with PD compared to the informal caregivers
of elderly care-recipients without PD using the nationally representative sample of National
Alliance for Caregivers (2004, 2009). This research question also estimated costs associated with
providing informal care to elderly individuals with and without PD. The caregiver burden as
estimated on the computed caregiver scale was similar among individuals with and without PD
(2.25 vs. 2.21). The average number of caregiving hours per week for care-recipients with PD
was higher than those without PD (PD:: No PD 27.51 (±35.04) hours: 21.62 (±28.71)). The
average annual costs of informal caregiving for care-recipients with and without PD were
approximately $14,448 and $11,355 respectively. However, these differences in terms of number
of hours of informal caregiving per week and annual costs of informal caregiving were not
statistically significant. After adjusting for care-recipient, caregiver characteristics and other
independent variables, caregiver burden and costs did not differ significantly between elderly
individuals with and without PD. One of the main reasons that we can speculate why we did not
observe statistically significant differences in formal caregiver burden and costs between these
two groups in bivariate and multivariate analyses may be the small sample size of the informal
caregivers of care-recipients with PD (N = 32). A noteworthy finding from this research question
was the association between the functional status of the care-recipients and caregiver burden. It
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was observed that ADL and IADL were significantly positively associated with caregiver burden
in all the three models. Previous studies conducted by Edwards & Ruettinger (2002) and Cifu et
al., (2006) also observed that higher caregiver burden was associated with increased difficulties
with ADL performance. Although prior studies have not examined the relationship between
IADL and caregiver burden, our study documents that increase in the number of difficulties with
IADLs was also associated with greater caregiver burden.
The third research of this dissertation used the nation-wide claims database of Humana
Medicare Advantage Part D enrollees to assess process and intermediate outcomes of diabetes
care among elderly individuals with CIC (T2DM and PD) compared to those without CIC
(T2DM without PD). Multivariable conditional logistic regressions revealed that elderly
individuals with CIC were less likely to meet the annual American Diabetes Association (ADA)
recommended annual HbA1c and lipid testing compared to elderly individuals without CIC.
However, multinomial conditional logistic regressions showed that elderly individuals with CIC
were more likely to achieve glycemic and lipid controls. These findings are consistent with a
study conducted among elderly veterans, which showed that veterans with CIC were more likely
to receive overall good outcomes for all 3quality measures (glycemic, blood pressure and low
density lipoprotein-cholesterol) combined (Woodard, Urech, Landrum, Wang, & Petersen,
2011). However, these findings were inconsistent with the findings from the study using the
INTERMED classification system for case complexity which found that among individuals with
T2DM, greater complexity was associated with higher HbA1c values (Fischer et al., 2000).
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CONCLUSIONS
This dissertation assessed the burden of illness among elderly individuals with PD in
three dimensions of economic burden of formal and informal caregiving, and the impact of CIC
on the process and intermediate outcomes of care. We found that elderly Medicare beneficiaries
with PD had significantly higher home healthcare use and expenditures compared to those
without PD. The differences in home healthcare use and expenditures among elderly Medicare
beneficiaries with and without PD were mainly explained by personal health behaviors such as
baseline resource use and need factors such as physical and mental health conditions. In terms of
economic burden of informal caregiving, we did not observe a significant difference in informal
caregiving costs between caregivers of elderly individuals with and without PD, despite the costs
of informal caregiving for elderly individuals with PD being 1.27 times higher than those
without PD. Individuals with CIC were less likely to achieve ADA recommended annual HbA1c
and lipid testing goals compared to those without CIC. However, individuals with CIC achieved
glycemic and lipid control outcomes. Thus, these findings taken together underscore the
advantage of using an integrated delivery system with better care coordination and providing
“holistic care approach.” As majority of elderly individuals with PD are community-dwelling,
novel intervention techniques are needed to be developed to reduce the informal caregiving
burden.
IMPLICATIONS OF THE STUDY
The findings from our three research questions have significant implications.
Reducing the cost curve and need for integrated care and following new care models such as
Patient Centered Medical Homes
From our first research question, it was observed that the home healthcare use and
expenditures were significantly higher among elderly Medicare beneficiaries with PD compared
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to those without PD and personal health behaviors such as the baseline resource use and need
factors such as physical and mental health conditions had the highest contribution to the
explained portions of the differences in home healthcare use and expenditures among elderly
Medicare beneficiaries with and without PD. Findings from this aim have health policy
implications in terms of reducing cost burden for Medicare, which is the single most important
payer of healthcare for the elderly. Although less than 5% of total Medicare spending is
accounted by home healthcare expenditures, Medicare home healthcare spending has grown
substantially over the past decade. It has been estimated that total Medicare home healthcare
expenditures increased from by 129% between 2000 and 2010 (Home Healthcare ServicesChapter 8) and the number of home healthcare users also increased from 2.5 million to 3.4
million between 2002-2010 (Health Care Spending-Medicare). The Center for Medicare and
Medicaid Services (CMS) has been exploring ways in which they can contain this escalating
home healthcare expenditures. As the post-regression decomposition technique results suggest
that need factors such as physical and mental health conditions which often co-occur, there is a
need for integrated care and following new care models such as Patient Centered Medical Homes
to better manage the issue of co-occurring chronic conditions in this geriatric population which
in turn may lead to better health outcomes and consequent reduction of the escalating cost curve.
Financial implications of informal caregiving burden and costs
The second research question of this study provided the first nationally representative
estimates of costs of informal caregiving of care-recipients with PD. The average annual costs of
informal caregiving for care-recipients with and without PD were approximately $14,448 and
$11,355 respectively. The high annual costs of informal care provided to the elderly individuals
with PD have significant financial implications. As the population of U.S. is aging, and there is
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an expected subsequent increase in the prevalence of PD, innovative intervention techniques
need to be developed which can be devoted towards reducing informal caregiving burden and
also curb the financial burdens of providing informal care.
Advantages of an Integrated Delivery System
From our third research question, we found that individuals with CIC were more likely to
achieve better intermediate glycemic and lipid outcomes. One of the characteristics of the
Medicare Advantage plans is that they follow the Integrated Delivery System (IDS) model. In
the IDS model, the primary physician serves as the gate-keeper and maintains proper referral
systems. The coordination of care among different types of specialists (Endocrinologists,
Neurologists etc.) is ensured in the IDS models which in turn could lead to better management of
individuals with CIC. Hence, this finding further underscores the benefits of following IDS
where good coordination of care is generally available.
LIMITATIONS
Findings from this study should be interpreted with caution as there are some limitations
associated with this study. For first research question (Aim 1), we did not have information on
the prescription drug expenditures. Previous research suggests that prescription drug
expenditures are one of the major drivers of the healthcare expenditures and so estimates from
the Aim 1 can be under-estimated due to lack of information on prescription drug expenditures.
The findings from Aim 1 are not generalizable to other populations or settings as we only used
fee-for-service enrollees and excluded HMO enrollees from the study sample. Users of home
healthcare may be different from non-users of home health care in unobserved variables. Aim 1
of this dissertation does not control for such selection bias. The Medicare 5% claims database did
not have many important and relevant variables that are associated with home healthcare use
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such as limitations of activities of daily living (ADL) and instrumental activities of daily living
(IADL). This may lead to underestimation of the explained portion of the estimated differences
in home healthcare expenditures among individuals with and without PD. However, by using a
representative sample of Medicare beneficiaries with linked Medicare claims, we are able to
estimate the extent to which unmeasured factors can underestimate explained portion of the
differences in expenditures among individuals with and without PD. In terms of our second
research question (Aim 2) of this dissertation we had some limitations as well. The study sample
was small with only 32 caregivers of care-recipients with PD. This small sample size may affect
the power of the analyses. We did not observe significant differences in informal caregiver
burden in the Aim 2, which can be mostly attributed to the small sample size of the informal
caregivers of care-recipients with PD. This data did not have information related to clinical
factors such as presence of physical (e.g. diabetes) and/or mental conditions (e.g. depression,
anxiety). Adjusting for comorbid conditions may explain more variance in the caregiver burden.
Moreover, duration and severity of diseases was unavailable. However, ADLs and IADLs may
serve as global proxies for severity of illness. Additionally, as this is a survey, presence of recall
bias cannot be ruled out. For our third research question (Aim 3) of this dissertation, we had
some limitations as well. This Aim used commercially enrolled elderly Medicare beneficiaries
and hence the findings from this study cannot be generalizable to other populations or settings
(e.g. fee-for-service Medicare beneficiaries). Moreover, laboratory values are available for only
one-third of the population. Unmeasured confounders such lifestyle risk factors (e.g. body mass
index and smoking status), physician specialty, duration and severity of PD could influence the
study outcomes.
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FUTURE RESEARCH
Future studies should be conducted to answer the questions that were not answered in this
dissertation, and those studies should also overcome the limitations of this dissertation. Using the
individual-level factors included in Aim 1of this dissertation, only 27% and 11% of the home
healthcare use and expenditures differences between elderly Medicare beneficiaries with and
without PD was explained. Some important factors such as ADL, IADL, and physical and mental
health status were not available in the Medicare 5% claims database. Intuitively these factors can
influence the home healthcare use and expenditures and hence future studies should include
these factors to understand their influence on the home healthcare use and expenditures among
elderly individuals with PD. In Aim 2 of this dissertation, we did not find an association between
PD and informal caregiver burden which can be mainly attributed to the small sample size of the
caregivers of care-recipients with PD. Future studies should try to overcome this problem by
using a large dataset such as the Health and Retirement Survey linked to Medicare claims, which
has an additional benefit of including the co-occurring chronic conditions which may also
influence the informal caregiving burden. In Aim 3 of this dissertation, we found that among
elderly individuals with PD and type 2 diabetes mellitus (T2DM), the rates of HbA1c and lipid
testing were significantly lower compared to elderly individuals with T2DM and without PD.
Future research needs to explore the reasons for lower rates of HbA1C and lipid testing among
elderly individuals with T2DM and PD and also devise appropriate interventions to overcome
the barriers to testing.
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